<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">LzX4WJZjtsCSJn7qGqkgDjb</article-id>
      <article-id pub-id-type="other">00009</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010000100009</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09400109</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010000100009</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>S&#237;ndrome metab&#243;lica em ambulat&#243;rio cardiol&#243;gico</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Barbosa</surname>
            <given-names>Jos&#233; Bonif&#225;cio</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silva</surname>
            <given-names>Antonio Augusto Moura da</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barbosa</surname>
            <given-names>Fabr&#237;cio de Flores</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Monteiro J&#250;nior</surname>
            <given-names>Francisco das Chagas</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Figueiredo Neto</surname>
            <given-names>Jos&#233; Albuquerque de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nina</surname>
            <given-names>Vinicius Jos&#233; da Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Waston Gon&#231;alves</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Figuer&#234;do</surname>
            <given-names>Eduardo Durans</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Melo Filho</surname>
            <given-names>Jos&#233; Xavier de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chein</surname>
            <given-names>Maria Beth&#226;nia da Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Lu&#237;s</named-content>
          <named-content content-type="state">Maranh&#227;o</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal do Maranh&#227;o</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>01</month>
        <year>2010</year>
      </pub-date>
      <volume>94</volume>
      <issue>1</issue>
      <fpage>46</fpage>
      <lpage>54</lpage>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>09</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>09</day>
          <month>12</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>05</day>
          <month>11</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: No Brasil, a preval&#234;ncia de s&#237;ndrome metab&#243;lica (SM) &#233; pouco conhecida em v&#225;rias regi&#245;es. OBJETIVO: Analisar a preval&#234;ncia da SM, seus componentes e a concord&#226;ncia entre dois crit&#233;rios diagn&#243;sticos numa popula&#231;&#227;o com idade &gt; 13 anos. M&#201;TODOS: Estudo transversal, realizado de junho a outubro de 2007, em 719 pacientes, em ambulat&#243;rios cardiol&#243;gicos de S&#227;o Lu&#237;s, MA. Mediu-se a press&#227;o arterial (PA), peso, altura, circunfer&#234;ncia abdominal e perfil lip&#237;dico. Avaliaram-se os fatores de risco para a SM segundo o crit&#233;rio da International Diabetes Federation (IDF). Raz&#245;es de preval&#234;ncia e intervalos de confian&#231;a de 95% foram estimados pela regress&#227;o de Poisson. RESULTADOS: A preval&#234;ncia da SM foi maior em ambos os sexos pelo conceito da IDF (62,3% em homens e 64,6% em mulheres), em rela&#231;&#227;o ao do National Cholesterol Education Program - Adult Treatment Prevention (NCEP ATPIII) (48,9% em homens e 59% em mulheres). Os componentes da SM mais prevalentes foram: hipertens&#227;o arterial sist&#234;mica HAS (87,2% e 86%); hipertrigliceridemia (84,4% e 82,5%); circunfer&#234;ncia abdominal alterada (77,8% e 100%); HDL-c baixo (58,1% e 49,9%); e glicemia alterada (59,9% e 51,9%), pelos conceitos NCEP ATPIII e IDF, respectivamente. Ap&#243;s an&#225;lise ajustada, idade &gt; 60 anos e &#237;ndice de massa corporal (IMC) &gt; 30 foram associados a um maior risco de SM (p &lt; 0,001). CONCLUS&#195;O: A preval&#234;ncia da SM foi bem maior que a popula&#231;&#227;o geral; a (HAS) foi o componente mais prevalente. Houve boa concord&#226;ncia entre os dois crit&#233;rios, sendo &#243;tima no sexo feminino e regular no masculino.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Sindrome metab&#243;lica</kwd>
        <kwd>institui&#231;&#245;es de assist&#234;ncia ambulatorial</kwd>
        <kwd>&#233;tica</kwd>
        <kwd>cardiologia</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>22</day>
        <month>09</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> CORONARIOPATIA AGUDA</p>
    <p>
      <bold>S&#237;ndrome metab&#243;lica em ambulat&#243;rio cardiol&#243;gico</bold>
    </p>
    <p>
      <bold>Jos&#233; Bonif&#225;cio Barbosa; Antonio Augusto Moura da Silva; Fabr&#237;cio de Flores Barbosa; Francisco das Chagas Monteiro J&#250;nior; Jos&#233; Albuquerque de Figueiredo Neto; Vinicius Jos&#233; da Silva Nina; Waston Gon&#231;alves Ribeiro; Eduardo Durans Figuer&#234;do; Jos&#233; Xavier de Melo Filho; Maria Beth&#226;nia da Costa Chein</bold>
    </p>
    <p>Faculdade de Medicina da Universidade Federal do Maranh&#227;o (UFMA/UDI Hospital), S&#227;o Lu&#237;s, MA - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> No Brasil, a preval&#234;ncia de s&#237;ndrome metab&#243;lica (SM) &#233; pouco conhecida em v&#225;rias regi&#245;es. </p>
    <p> OBJETIVO: Analisar a preval&#234;ncia da SM, seus componentes e a concord&#226;ncia entre dois crit&#233;rios diagn&#243;sticos numa popula&#231;&#227;o com idade <underline>&gt;</underline> 13 anos. </p>
    <p><bold>M&#201;TODOS: </bold> Estudo transversal, realizado de junho a outubro de 2007, em 719 pacientes, em ambulat&#243;rios cardiol&#243;gicos de S&#227;o Lu&#237;s, MA. Mediu-se a press&#227;o arterial (PA), peso, altura, circunfer&#234;ncia abdominal e perfil lip&#237;dico. Avaliaram-se os fatores de risco para a SM segundo o crit&#233;rio da International Diabetes Federation (IDF). Raz&#245;es de preval&#234;ncia e intervalos de confian&#231;a de 95% foram estimados pela regress&#227;o de Poisson. </p>
    <p><bold>RESULTADOS: </bold> A preval&#234;ncia da SM foi maior em ambos os sexos pelo conceito da IDF (62,3% em homens e 64,6% em mulheres), em rela&#231;&#227;o ao do National Cholesterol <italic>Education Program - Adult Treatment Prevention</italic> (NCEP ATPIII) (48,9% em homens e 59% em mulheres). Os componentes da SM mais prevalentes foram: hipertens&#227;o arterial sist&#234;mica HAS (87,2% e 86%); hipertrigliceridemia (84,4% e 82,5%); circunfer&#234;ncia abdominal alterada (77,8% e 100%); HDL-c baixo (58,1% e 49,9%); e glicemia alterada (59,9% e 51,9%), pelos conceitos NCEP ATPIII e IDF, respectivamente. Ap&#243;s an&#225;lise ajustada, idade <underline>&gt;</underline> 60 anos e &#237;ndice de massa corporal (IMC) <underline>&gt;</underline> 30 foram associados a um maior risco de SM (p &lt; 0,001). </p>
    <p><bold>CONCLUS&#195;O: </bold> A preval&#234;ncia da SM foi bem maior que a popula&#231;&#227;o geral; a (HAS) foi o componente mais prevalente. Houve boa concord&#226;ncia entre os dois crit&#233;rios, sendo &#243;tima no sexo feminino e regular no masculino.</p>
    <p><bold>Palavras-chave: </bold> Sindrome metab&#243;lica, institui&#231;&#245;es de assist&#234;ncia ambulatorial, &#233;tica, cardiologia.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A s&#237;ndrome metab&#243;lica (SM) consiste na presen&#231;a de altera&#231;&#245;es glic&#237;dicas (hiperinsulinemia, resist&#234;ncia &#224; insulina, intoler&#226;ncia &#224; glicose ou diabete melito tipo 2) e lip&#237;dicas (aumento de triglicer&#237;deos e LDL-colesterol e diminui&#231;&#227;o do HDL-colesterol), da obesidade abdominal, da hipertens&#227;o arterial (HA) e de dist&#250;rbios da coagula&#231;&#227;o (aumento da ades&#227;o plaquet&#225;ria e do inibidor do ativador do plasminog&#234;nio-PAI-1). H&#225; tamb&#233;m um estado pr&#243;-inflamat&#243;rio, com aumento da prote&#237;na C reativa, fator de necrose tumoral alfa e interleucina 6<sup>1</sup>.</p>
    <p>H&#225; uma estreita associa&#231;&#227;o de causa-efeito entre a SM e doen&#231;as cardiovasculares (DCVs). A SM aumenta a mortalidade geral em cerca de uma vez e meia e a cardiovascular em aproximadamente duas vezes e meia<sup>2</sup>. Predisposi&#231;&#227;o gen&#233;tica, alimenta&#231;&#227;o inadequada e sedentarismo contribuem para o seu desencadeamento<sup>3,4</sup>.</p>
    <p>Em 1998, a <italic>World Health Organization</italic> (WHO) desenvolveu um crit&#233;rio de defini&#231;&#227;o para SM incluindo, al&#233;m da hipertens&#227;o arterial sist&#234;mica (HAS) e da dislipidemia, a obesidade e a microalbumin&#250;ria<sup>5</sup>. Em 2001, o <italic>National Institute of Health</italic>, por meio do <italic>National Cholesterol Education Program</italic> (NCEP), e o <italic>3<sup>rd</sup> Adult Treatment Panel</italic> (ATP III) sugeriram outra defini&#231;&#227;o da SM, sem incluir peso e microalbumin&#250;ria, necessitando de pelo menos tr&#234;s componentes anormais<sup>6</sup>.</p>
    <p>Em abril de 2005, foi publicada a primeira Diretriz Brasileira de Diagn&#243;stico e Tratamento da S&#237;ndrome Metab&#243;lica, com o apoio da Sociedade Brasileira de Cardiologia, que utilizou o crit&#233;rio NCEP ATPIII para definir SM<sup>7</sup>. Em 2006, a IDF formulou nova defini&#231;&#227;o para SM, considerando as diferentes etnias<sup>8</sup>.</p>
    <p>A SM aumenta com a idade<sub>,</sub> em homens e mulheres, alcan&#231;ando 50% entre 60 e 69 anos<sup>9,10</sup>. Um estudo recente mostrou que cerca de 20% a 25% das crian&#231;as e adolescentes obesos apresentam resist&#234;ncia &#224; insulina, elemento-chave da SM e que pode levar ao diabete tipo 2<sup>10,11</sup>.</p>
    <p>Em Ribeir&#227;o Preto, S&#227;o Paulo, um inqu&#233;rito populacional realizado em adultos com idades entre 22 e 28 anos, publicado em 2007, mostrou preval&#234;ncia de 7,6%<sup>12</sup>. Dados da WHO mostram que em pa&#237;ses em desenvolvimento, a obesidade aumentou duas a tr&#234;s vezes na &#250;ltima d&#233;cada<sup>13</sup>.</p>
    <p>Existem in&#250;meros estudos internacionais sobre SM, sendo escassos no Brasil, raz&#227;o do interesse em estudar essa entidade em nosso meio, com grande heterogeneidade de fatores relacionados &#224; mesma, como os de ordem demogr&#225;fica e os inerentes ao estilo de vida da popula&#231;&#227;o.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Foi realizado um estudo transversal - aprovado pelo Comit&#234; de &#201;tica em Pesquisa do Hospital Universit&#225;rio da Universidade Federal do Maranh&#227;o, em 719 pacientes examinados em ambulat&#243;rios de cardiologia na cidade de S&#227;o Lu&#237;s (MA), entre 1&#186; de junho e 1&#186; de outubro de 2007, com idade entre 13 e 96 anos (m&#233;dia de 56,3 anos). A todos os indiv&#237;duos foi apresentado um Termo de Consentimento Livre e Esclarecido, assinado em caso de concord&#226;ncia. Inclu&#237;ram-se todos os que compareceram ao ambulat&#243;rio de cardiologia no per&#237;odo mencionado, exceto os com idade inferior a 13 anos, os que n&#227;o tinham exames laboratoriais e os que se negaram a faz&#234;-los, mulheres gr&#225;vidas e pacientes com ascite. Foi aplicada a todos os sujeitos uma ficha-protocolo contendo: nome, sexo, idade, cor da pele, escolaridade, profiss&#227;o, renda familiar, antecedentes m&#243;rbidos pessoais, atividade f&#237;sica, tabagismo, etilismo, medida da press&#227;o arterial (PA), circunfer&#234;ncia abdominal, altura, peso, &#237;ndice de massa corporal (IMC), glicemia em jejum, triglicer&#237;deos (TG), colesterol total (CT), HDL-colesterol e LDL-colesterol.</p>
    <p>O conceito de SM foi definido conforme as diretrizes do NCEP ATP III e da IDF<sup>6,7</sup>, levando em considera&#231;&#227;o os seguintes fatores de risco: circunfer&#234;ncia abdominal, TG, HDL-c, PA e glicemia em jejum. O diagn&#243;stico de SM pelo NCEP ATPIII consiste na altera&#231;&#227;o de tr&#234;s dos fatores acima mencionados, enquanto que pela IDF o mesmo &#233; feito pelo aumento da circunfer&#234;ncia abdominal acrescido de pelo menos dois outros fatores de risco. Tanto pelo conceito do NCEP como pelo da IDF, os valores alterados dos TG (<underline>&gt;</underline> 150 ml/dl), PA (<underline>&gt;</underline> 130/85 mmHg) e HDL-c (&lt; 40 para homens e &lt; 50 para mulheres) s&#227;o os mesmos. A circunfer&#234;ncia abdominal alterada pelo NCEP ATPIII &#233; <underline>&gt;</underline> 102 cm para homens e <underline>&gt;</underline> 88 cm para mulheres, enquanto que pela IDF os valores s&#227;o <underline>&gt;</underline> 90 cm para homens e <underline>&gt;</underline> 80 cm para mulheres, valores esses propostos para os povos sul-americanos. O valor da glicemia em jejum alterada em ambos os conceitos, NCEP e IDF, foi considerado <underline>&gt;</underline> 100mg/dl. Avaliou-se tamb&#233;m a rela&#231;&#227;o TG/HDL-c alterada <underline>&gt;</underline> 3,5. Pelo &#237;ndice Kappa de Cohen<sup>14</sup> foi avaliada a concord&#226;ncia no diagn&#243;stico de SM pelos dois crit&#233;rios.</p>
    <p>A medida da PA foi realizada pelo m&#233;todo indireto com t&#233;cnica auscultat&#243;ria e esfigmoman&#244;metros aner&#243;ides calibrados. O manguito foi selecionado adequando-se ao bra&#231;o e colocado sem deixar folgas, cerca de 2 a 3 cent&#237;metros acima da fossa cubital. O n&#237;vel da press&#227;o sist&#243;lica foi estimado palpando-se o pulso radial e inflando o manguito at&#233; seu desaparecimento. Ap&#243;s inflar rapidamente e aguardar um minuto, a camp&#226;nula do estetosc&#243;pio foi colocada sobre a art&#233;ria braquial. O manguito foi inflado rapidamente at&#233; ultrapassar em 20 a 30 mmHg o n&#237;vel estimado da press&#227;o sist&#243;lica. A defla&#231;&#227;o foi feita lentamente (velocidade de 2 a 4 mmHg por segundo) sendo a press&#227;o sist&#243;lica determinada pela ausculta do primeiro som (fase I de Korotkoff) e a diast&#243;lica determinada no desaparecimento do som (fase V de Korotkoff). Os pacientes n&#227;o deveriam ter praticado exerc&#237;cio f&#237;sico 60 a 90 minutos antes da avalia&#231;&#227;o, ingerido bebidas alco&#243;licas e caf&#233;, ou fumado 30 minutos antes da medida da press&#227;o arterial. Os indiv&#237;duos encontravam-se sentados, h&#225; pelo menos cinco minutos em repouso, em ambiente calmo, sem roupa no membro superior direito, mantendo as pernas descruzadas, p&#233;s apoiados no ch&#227;o, dorso recostado na cadeira e relaxado, com o bra&#231;o apoiado na altura do cora&#231;&#227;o, com a palma da m&#227;o voltada para cima e o cotovelo ligeiramente fletido, sem falar durante o procedimento. A medida foi realizada em dois momentos diferentes, com intervalo de aproximadamente dois minutos. O n&#237;vel mais baixo foi considerado a medida da PA<sup>15</sup>. Foram classificados como hipertensos pacientes com press&#227;o arterial sist&#243;lica (PAS) <underline>&gt;</underline> 140 mmHg e/ou press&#227;o arterial diast&#243;lica (PAD) <underline>&gt;</underline> 90 mmHg, ou em uso de anti-hipertensivos<sup>16</sup>.</p>
    <p>O peso corporal foi obtido em balan&#231;a eletr&#244;nica (precis&#227;o de 0,1 kg) com a bexiga vazia e o indiv&#237;duo portando apenas roupas &#237;ntimas. A estatura foi obtida com estadi&#244;metro de balan&#231;a, com o indiv&#237;duo descal&#231;o e com precis&#227;o de 0,5 cm. Calculou-se o IMC (IMC = Peso/Altura)<sup>2</sup>, conforme recomenda&#231;&#227;o da Organiza&#231;&#227;o Mundial da Sa&#250;de (OMS) para avalia&#231;&#227;o do estado nutricional<sup>13</sup>. Foram utilizados os seguintes pontos de corte para classifica&#231;&#227;o dos indiv&#237;duos quanto ao IMC (kg/m<sup>2</sup>): normal &lt; 25; sobrepeso de 25 a 29,99 e obeso <underline>&gt;</underline> 30. Foi considerado excesso de peso quando esse &#237;ndice era <underline>&gt;</underline> 25 kg/m&#178;. A medida da circunfer&#234;ncia abdominal foi feita no ponto m&#233;dio entre a crista il&#237;aca e a face externa da &#250;ltima costela, com fita m&#233;trica inel&#225;stica, em posi&#231;&#227;o ortost&#225;tica, com o paciente em p&#233;, sem roupa no t&#243;rax, e no final da expira&#231;&#227;o<sup>17</sup>.</p>
    <p>Os exames bioqu&#237;micos foram feitos em aparelho ADVIA 1650. A concentra&#231;&#227;o de LDL-c foi calculada pela f&#243;rmula de Friedwald<sup>18</sup>.</p>
    <p>Foram considerados tabagistas os que faziam uso de fumo, independentemente da quantidade de cigarros, no per&#237;odo da realiza&#231;&#227;o da pesquisa. N&#227;o foram considerados os tabagistas passivos.</p>
    <p>O uso de &#225;lcool foi considerado em pessoas que bebiam independentemente do tipo e da quantidade.</p>
    <p>Foram considerados sedent&#225;rios os pacientes que n&#227;o faziam atividade f&#237;sica pelo menos tr&#234;s vezes por semana, durante trinta minutos por dia<sup>8</sup>.</p>
    <p>O grupo controle foi constitu&#237;do por indiv&#237;duos sem SM por ambos os crit&#233;rios, NCEP ATPIII e IDF.</p>
    <p>As an&#225;lises estat&#237;sticas foram realizadas no Stata 9.0. Na avalia&#231;&#227;o da associa&#231;&#227;o entre os fatores de risco estudados e a preval&#234;ncia de SM, segundo o crit&#233;rio do IDF, empregou-se o modelo de regress&#227;o de Poisson<sup>18</sup>. Estudos demonstram que quando a preval&#234;ncia do evento for superior a 10%, o uso do modelo de regress&#227;o log&#237;stica para a estima&#231;&#227;o do <italic>odds ratio</italic> promove uma superestima&#231;&#227;o do risco. Foram calculadas as raz&#245;es de preval&#234;ncia pelo m&#233;todo robusto e seu respectivo intervalo de confian&#231;a de 95%. O n&#237;vel de signific&#226;ncia adotado foi de 5%. Todas as vari&#225;veis que apresentaram p &lt; 0,20 na an&#225;lise n&#227;o ajustada foram selecionadas para a an&#225;lise multivari&#225;vel. Na an&#225;lise ajustada foi utilizado o m&#233;todo de sele&#231;&#227;o de vari&#225;veis por passos (<italic>stepwise</italic>) com elimina&#231;&#227;o retr&#243;grada. Ficaram no modelo final apenas aquelas vari&#225;veis associadas a um valor de P &lt; 0,10<sup>19</sup>.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>As caracter&#237;sticas basais dos sujeitos estudados em ambulat&#243;rio de cardiologia est&#227;o resumidas na <xref ref-type="table" rid="t01">Tabela 1</xref>. A idade m&#233;dia dos homens foi de 56 anos e das mulheres, 58 anos. Entre os antecedentes m&#243;rbidos pessoais - insufici&#234;ncia coronariana (ICo), acidente vascular cerebral (AVC), doen&#231;a vascular perif&#233;rica (DVP), diabete melito (DM) e HAS -, somente a ICo foi diferente segundo o sexo, com 23,4% entre os homens, contra 13,9% entre as mulheres (p &lt; 0,001). A preval&#234;ncia da SM foi maior em ambos os sexos pelo conceito da IDF (62,3% para homens e 64,6% para mulheres), quando comparada com o do NCEP (48,9% para homens e 59% para mulheres). Entre as vari&#225;veis lip&#237;dicas, as m&#233;dias do CT (194 mg/dl), do HDL-c (51 mg/dl) e do LDL-c (118 mg/dl) foram mais elevadas entre as mulheres que entre os homens (CT 183 mg/dl, HDL-c 44 mg/dl e LDL-c 108,5 mg/dl). As m&#233;dias dos TG (141 mg/dl) e da rela&#231;&#227;o CT/HDL (4,1) foram maiores entre os homens em rela&#231;&#227;o &#224;s mulheres, TG (120 mg/dl) e CT/HDL (-3,8). As m&#233;dias dos TG (141 mg/dl) e da rela&#231;&#227;o TG/HDL-c <underline>&gt;</underline> 3,8 (38,3) foram maiores entre os homens em rela&#231;&#227;o &#224;s mulheres, TG (120 mg/dl) e TG/HDL-c (19,2). No sexo masculino houve 30,7% de HDL-c baixo em rela&#231;&#227;o a 42,6% no sexo feminino, enquanto que 68,7% dos homens apresentaram hipertrigliceridemia contra 54,6% das mulheres. Obesidade, vari&#225;veis hemodin&#226;micas, tabagismo e atividade f&#237;sica n&#227;o tiveram diferen&#231;a estatisticamente significante entre homens e mulheres. O uso de &#225;lcool foi significativamente maior entre os homens (49,2%) que entre as mulheres (19,5%).</p>
    <p content-type="asset">
      <table-wrap id="t01">
        <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt01.jpg"/></table-wrap>
    </p>
    <p>A <xref ref-type="table" rid="t02">Tabela 2</xref> descreve as caracter&#237;sticas dos sujeitos estudados de acordo com as defini&#231;&#245;es de SM pelo NCEP e IDF. Entre os 719 indiv&#237;duos avaliados, 243 n&#227;o tinham SM, 391 indiv&#237;duos tinham pelo conceito do NCEP e 457 pelo da IDF. Indiv&#237;duos com SM pelos dois conceitos eram mais velhos, tinham mais antecedentes m&#243;rbidos pessoais (DM, HAS e ICo), glicemia em jejum alterada e vari&#225;veis lip&#237;dicas alteradas (HDL-c mais baixo, LDL-c mais alto, rela&#231;&#227;o CT/HDL-c mais elevada, hipertrigliceridemia, rela&#231;&#227;o TG/HDL-c <underline>&gt;</underline> 3,8). Eram tamb&#233;m mais pesados e mais baixos, com IMC, circunfer&#234;ncia da cintura e press&#227;o arterial sist&#243;lica e diast&#243;lica mais elevadas. Tinham mais obesidade, excesso de peso, circunfer&#234;ncia da cintura alterada e hipertens&#227;o. Comparando-se indiv&#237;duos com e sem SM, n&#227;o foram diferentes os antecedentes m&#243;rbidos pessoais (AVC e DVP), colesterol total e as vari&#225;veis do estilo de vida (tabagismo, uso de &#225;lcool e atividade f&#237;sica).</p>
    <p content-type="asset">
      <table-wrap id="t02">
        <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt02.jpg"/></table-wrap>
    </p>
    <p>A concord&#226;ncia geral medida pelo Kappa foi de 0,70, p &lt; 0,001. No sexo feminino, o valor do Kappa foi 0,82 (p &lt; 0,001) e no masculino foi 0,58 (p &lt; 0,001).</p>
    <p>A <xref ref-type="table" rid="t03">Tabela 3</xref> mostra a an&#225;lise n&#227;o ajustada dos fatores de risco para SM pelo crit&#233;rio da IDF. Pacientes com idade <underline>&gt;</underline> 40 anos, escolaridade <underline>&lt;</underline> 8 anos de estudo, renda familiar <underline>&lt;</underline> 1.000 reais, que viviam com companheiro (casados ou em uni&#227;o consensual) e sobrepeso e/ou obesidade tiveram maior risco de SM.</p>
    <p content-type="asset">
      <table-wrap id="t03">
        <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt03.jpg"/></table-wrap>
    </p>
    <p>A <xref ref-type="table" rid="t4">Tabela 4</xref> mostra a an&#225;lise ajustada dos fatores de risco para SM pelo crit&#233;rio da IDF. Teve signific&#226;ncia estat&#237;stica idade <underline>&gt;</underline> 60 anos e IMC <underline>&gt;</underline> 30.</p>
    <table-wrap id="t4">
      <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt04.jpg"/></table-wrap>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Utilizaram-se neste estudo, dois conceitos para defini&#231;&#227;o da SM, o do NCEP ATPIII (I Diretriz Brasileira de Diagn&#243;stico e Tratamento da S&#237;ndrome Metab&#243;lica) e o da IDF, sendo avaliados 719 indiv&#237;duos em ambulat&#243;rio de cardiologia. A preval&#234;ncia da SM foi de 54,4% (391 casos) segundo o NCEP e de 63,6% (457 casos) de acordo com o IDF, sendo mais prevalente no sexo feminino. Os componentes da SM mais prevalentes foram: HAS, hipertrigliceridemia e circunfer&#234;ncia abdominal alterada, seguidos de HDL-c baixo e glicemia alterada. Entre as comorbidades associadas, a ICo e o AVC foram as mais presentes. A SM foi mais prevalente entre os indiv&#237;duos de baixa renda e de idade mais elevada. Tabagismo, uso de &#225;lcool e atividade f&#237;sica n&#227;o estiveram significantemente associados &#224; SM. Ap&#243;s a an&#225;lise ajustada dos fatores de risco para SM, pelo crit&#233;rio da IDF, idade <underline>&gt;</underline> 60 anos e IMC <underline>&gt;</underline> 30 foram os que estiveram significantemente associados a um maior risco de SM.</p>
    <p>
      <bold>Preval&#234;ncia de s&#237;ndrome metab&#243;lica geral e segundo sexo</bold>
    </p>
    <p>Em um estudo na popula&#231;&#227;o urbana da Cor&#233;ia, em indiv&#237;duos com idade de 30 a 80 anos, pelo crit&#233;rio do NCEP ATP III, a preval&#234;ncia da SM foi de 16% em homens e 10,7% em mulheres<sup>20</sup>. J&#225; pela IDF, a preval&#234;ncia foi de 29% em homens e 16,8% em mulheres. Na cidade do Porto, em Portugal<sup>21</sup>, um estudo com 1.436 adultos (homens e mulheres) mostrou preval&#234;ncia de SM de 23,9% (27% em mulheres e 19,1% em homens) pelo crit&#233;rio do NCEP ATPIII. Em Taiwan, em 5.936 indiv&#237;duos com idade entre 20 e 79,9 anos, a preval&#234;ncia de SM foi de 15,7% pelo conceito do NCEP ATPIII e de 14,3% pelo da IDF<sup>22</sup>. Em um estudo realizado nos Estados Unidos<sup>23</sup>, com 3.601 participantes com idade variando entre 20 e 70 anos, a preval&#234;ncia de SM foi de 34,5% pelo conceito do NCEP ATPIII (33,7% entre os homens e 35,4% entre as mulheres), e de 39,% pelo IDF (39,9% nos homens e 38,1% nas mulheres). Na Dinamarca<sup>24</sup>, um estudo entre 2.493 sujeitos, com idade entre 41 e 72 anos, mostrou preval&#234;ncia de 21% (17,5% para homens e 23,8% para mulheres) pela IDF e de 16% (14,3% para homens e 18,6% para mulheres) pelo NCEP ATPIII. Em 2007, 1.007 indiv&#237;duos foram avaliados em Talca, Chile, com idade de 18 a 74 anos<sup>25</sup>, mostrando preval&#234;ncia da SM pelos conceitos do NCEP ATPIII e IDF de 36,4% e 29,5%, respectivamente.</p>
    <p>No Hospital Universit&#225;rio de Santa Catarina<sup>26</sup>, pelo conceito da IDF, a preval&#234;ncia da SM foi de 21,9% no sexo feminino e 19,4% no masculino. Em Vit&#243;ria, Esp&#237;rito Santo<sup>27</sup>, pelo NCEP ATPIII, a preval&#234;ncia de SM em 1.663 indiv&#237;duos com idade entre 25 e 64 anos foi de 29,8%. Em uma &#225;rea rural do semi&#225;rido baiano, foram estudados 240 indiv&#237;duos com idade <underline>&gt;</underline> 25 anos<sup>28</sup> e, pelo crit&#233;rio do NCEP ATPIII, a preval&#234;ncia da SM foi de 30% (38,4% em mulheres e 18,6% em homens).</p>
    <p>Neste estudo, a preval&#234;ncia de SM, 54,4% segundo o NCEP e 63,6% de acordo com o IDF, foi mais elevada do que nos estudos acima citados, pois a amostra aqui estudada foi formada por pacientes atendidos em ambulat&#243;rio de cardiologia, a maioria com doen&#231;as cardiovasculares. Houve maior preval&#234;ncia da SM no sexo feminino como nos estudos da Dinamarca<sup>24</sup>, Santa Catarina<sup>26</sup> e da cidade do Porto<sup>21</sup>, diferente dos estudos da Cor&#233;ia<sup>20</sup>, Estados Unidos da Am&#233;rica<sup>24</sup> e Talca (Chile)<sup>25</sup>, onde a preval&#234;ncia foi maior no sexo masculino.</p>
    <p>
      <bold>Preval&#234;ncia dos componentes da s&#237;ndrome metab&#243;lica</bold>
    </p>
    <p>Um estudo dinamarqu&#234;s<sup>24</sup> mostrou maior preval&#234;ncia dos componentes da SM: obesidade (38,6%), HDL-c baixo (37,1%) e HAS (34%), enquanto neste estudo prevaleceram: HAS (87,2%), hipertrigliceridemia (84,4%) e HDL-c baixo (58,1%), pelo conceito do NCEP ATP III. Os n&#237;veis de CT, LDL-c e os n&#237;veis de TG foram mais elevados no estudo da Dinamarca<sup>24</sup>, enquanto que os n&#237;veis de HDL-c baixo foram mais altos neste estudo. A rela&#231;&#227;o CT/HDL-c foi maior no estudo dinamarqu&#234;s (NCEP ATPIII), semelhante ao observado neste trabalho. A presen&#231;a de 27,7% de DM neste estudo foi bem maior do que os 7% relatados no trabalho dinamarqu&#234;s<sup>24</sup>.</p>
    <p>A ingest&#227;o de &#225;lcool e atividade f&#237;sica foram mais prevalentes neste estudo, ao contr&#225;rio do tabagismo, mais frequente no trabalho dinamarqu&#234;s<sup>24</sup> (44% contra 7,4%).</p>
    <p>Em um estudo no semi&#225;rido baiano<sup>28</sup>, o HDL-c baixo (70,4%) e a eleva&#231;&#227;o da PA (57,1%) foram os componentes da SM mais prevalentes, enquanto que neste estudo foram: excesso de peso e obesidade (92,9%), HAS (87,2%) e hipertrigliceridemia (84,4%). Neste estudo, a obesidade abdominal, excesso de peso e redu&#231;&#227;o do HDL-c foram mais prevalentes no sexo masculino, ao contr&#225;rio do que ocorreu no semi&#225;rido baiano, onde a maior preval&#234;ncia desses fatores foi observada no sexo feminino.</p>
    <p>
      <bold>Concord&#226;ncia entre as duas defini&#231;&#245;es da s&#237;ndrome metab&#243;lica</bold>
    </p>
    <p>A concord&#226;ncia geral, medida pelo kappa, foi considerada boa, indicando que ambos os crit&#233;rios podem ser utilizados na pr&#225;tica cl&#237;nica. A concord&#226;ncia foi &#243;tima no sexo feminino e regular no sexo masculino, sugerindo que os crit&#233;rios atualmente utilizados n&#227;o est&#227;o muito adequados para o sexo masculino (concord&#226;ncia regular).</p>
    <p>Possivelmente, a menor concord&#226;ncia no diagn&#243;stico de SM entre os dois crit&#233;rios no sexo masculino decorreu do crit&#233;rio utilizado para caracterizar circunfer&#234;ncia da cintura alterada. Pelo crit&#233;rio da IDF, n&#227;o h&#225; diferen&#231;a na preval&#234;ncia de circunfer&#234;ncia da cintura alterada entre os sexos, enquanto pelo NCEP ATPIII, h&#225; diferen&#231;a, pois 64,6% das mulheres e 43,8% dos homens t&#234;m circunfer&#234;ncia da cintura alterada. Isso sugere que o crit&#233;rio de diagn&#243;stico de circunfer&#234;ncia da cintura alterada utilizado pelo NCEP ATPIII para homens talvez esteja inadequado e tenha sido respons&#225;vel pela baixa concord&#226;ncia observada.</p>
    <p>Os dados deste estudo s&#227;o semelhantes aos encontrados por Cristal Lee e cols, em um trabalho com 22.403 sujeitos e idade <underline>&gt;</underline> 35 anos, que mostram uma &#243;tima concord&#226;ncia para mulheres entre os dois conceitos<sup>29</sup>. Clara Kelliny e cols.<sup>30</sup>, em um trabalho com 1.218 indiv&#237;duos com idade m&#233;dia de 42 anos, mostraram concord&#226;ncia geral de 0,82 entre os conceitos<sup>30</sup>.</p>
    <p>
      <bold>Fatores associados &#224; s&#237;ndrome metab&#243;lica.</bold>
    </p>
    <p>Neste estudo, a obesidade (IMC <underline>&gt;</underline> 30kg/m&#178;), ap&#243;s an&#225;lise ajustada dos fatores de risco, esteve significantemente associada &#224; SM. Esse resultado foi observado em v&#225;rios outros estudos, como EUA<sup>23</sup>, Chile<sup>25</sup>, bem como no Brasil, no estudo de Vit&#243;ria (ES)<sup>27</sup> e do semi&#225;rido baiano<sup>28</sup>. Possivelmente esse fato tenha ocorrido pela redu&#231;&#227;o de atividade f&#237;sica e aumento da ingest&#227;o de grandes quantidades de calorias nessas popula&#231;&#245;es.</p>
    <p>Entre os americanos<sup>23</sup>, a preval&#234;ncia da SM foi maior nos indiv&#237;duos de maior renda, ao contr&#225;rio deste estudo, no qual a preval&#234;ncia foi mais elevada em pessoas com menor renda. Tabagismo e ingest&#227;o de &#225;lcool estiveram independentemente associados &#224; SM no trabalho americano<sup>23</sup>, o que n&#227;o ocorreu neste trabalho.</p>
    <p>Neste estudo, a preval&#234;ncia da SM aumentou com a idade, o mesmo acontecendo nos estudos realizados no semi&#225;rido baiano<sup>28</sup>, em Vit&#243;ria<sup>27</sup>, Talca<sup>25</sup> e nos Estados Unidos<sup>23</sup>.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>O estudo mostrou que a preval&#234;ncia da SM em ambulat&#243;rio cardiol&#243;gico foi bem maior que a popula&#231;&#227;o geral; a HAS foi o componente mais prevalente. Houve boa concord&#226;ncia geral entre os dois crit&#233;rios, sendo &#243;tima para o sexo feminino e regular para o sexo masculino.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo foi financiado porUDI Hospital.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Jos&#233; Bonif&#225;cio Barbosa pela Universidade Federal do Maranh&#227;o - UFMA.</p>
    <p>
      <fn id="back" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Jos&#233; Bonif&#225;cio Barbosa </p>
        <p> Faculdade de Medicina da Universidade Federal do Maranh&#227;o </p>
        <p> UFMA/UDI Hospital </p>
        <p> S&#227;o Lu&#237;s, MA - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="josebbarbosa@uol.com.br">josebbarbosa@uol.com.br</email>, </p>
        <p>
          <email xlink:href="jbarbosa@cardiol.br">jbarbosa@cardiol.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 11/09/08; revisado recebido em 05/11/08; aceito em 09/12/08.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Alberti KGMM,    Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic    syndrome: a new worldwide definition. Lancet. 2005; 366: 1059-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>IDF Epidemiology Task Force Consensus Group: The metabolic syndrome: a new worldwide definition</article-title>
          <source>Lancet</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1059</fpage>
          <lpage>62</lpage>
          <volume>366</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Alberti</surname>
              <given-names>KGMM</given-names>
            </name>
            <name>
              <surname>Zimmet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Chew GT, Gan    SK, Watts GF. Revisiting the metabolic syndrome. Med J Aust. 2006; 185: 445-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Revisiting the metabolic syndrome</article-title>
          <source>Med J Aust</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>445</fpage>
          <lpage>9</lpage>
          <volume>185</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chew</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Gan</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Watts</surname>
              <given-names>GF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Iese AD, Mayer-Davis    EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic    perspective. Epidemiol Rev. 1998; 20: 157-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Development of the multiple metabolic syndrome: an epidemiologic perspective</article-title>
          <source>Epidemiol Rev</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>157</fpage>
          <lpage>72</lpage>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Iese</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Mayer-Davis</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Haffner</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Barker DJP,    Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of    effects and biological basis. Int J Epidemiol. 2002; 31: 1235-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Fetal origins of adult disease: strength of effects and biological basis</article-title>
          <source>Int J Epidemiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1235</fpage>
          <lpage>9</lpage>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Barker</surname>
              <given-names>DJP</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Forsen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Osmond</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO consultation; 1999.</mixed-citation>
        <element-citation publication-type="book">
          <source>Definition, diagnosis and classification of diabetes mellitus and its complications</source>
          <date>
            <year>1999</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Third Report    of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,    Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment    Panel III) Final Report. Circulation. 2002; 106: 3143-421.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report</article-title>
          <source>Circulation</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>3143</fpage>
          <lpage>421</lpage>
          <volume>106</volume>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Sociedade Brasileira    de Cardiologia. I Diretriz brasileira de diagn&#243;stico e tratamento da    s&#237;ndrome metab&#243;lica. Arq Bras Cardiol. 2005; 84 (supl I): 1-28.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>I Diretriz brasileira de diagn&#243;stico e tratamento da s&#237;ndrome metab&#243;lica</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1</fpage>
          <lpage>28</lpage>
          <volume>84</volume>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Alberti KG,    Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus    Statement from the International Diabetes Federation. Diabet Med. 2006; 23 (5):    469-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Metabolic syndrome - a new world-wide definition: A Consensus Statement from the International Diabetes Federation</article-title>
          <source>Diabet Med</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>469</fpage>
          <lpage>80</lpage>
          <issue>5</issue>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Alberti</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Zimmet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Prentice AM.    The emerging epidemic of obesity in developing countries. Int J Epidemiol. 2006;    35 (1): 93-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The emerging epidemic of obesity in developing countries</article-title>
          <source>Int J Epidemiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>93</fpage>
          <lpage>9</lpage>
          <issue>1</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Prentice</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Ford ES, Giles    WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002;    287 (16): 356-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of the metabolic syndrome among US adults</article-title>
          <source>JAMA</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>356</fpage>
          <lpage>9</lpage>
          <issue>16</issue>
          <volume>287</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ford</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Giles</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Rappaport EB,    Usher DC. Obesity, insulin resistance, and type 2 diabetes in children and adolescents.    Pediatr Ann. 2006; 35 (11): 822-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Obesity, insulin resistance, and type 2 diabetes in children and adolescents</article-title>
          <source>Pediatr Ann</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>822</fpage>
          <lpage>6</lpage>
          <issue>11</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rappaport</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Usher</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Bustos P, Silva    AA, Amigo H, Bettiol H, Barbieri MA. Metabolic syndrome in young adults from    two socioeconomic Latin American settings. NMCD. Nutr Metab Cardiovasc Dis.    2007; 17: 581-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Metabolic syndrome in young adults from two socioeconomic Latin American settings</article-title>
          <source>NMCD. Nutr Metab Cardiovasc Dis</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>581</fpage>
          <lpage>9</lpage>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bustos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Amigo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bettiol</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Barbieri</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Holt R. The    Food and Agriculture Organization / World Health Organization expert report    on diet, nutrition and prevention of chronic diseases. Diabetes Obes Metab.    2003; 5 (5): 354.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The Food and Agriculture Organization / World Health Organization expert report on diet, nutrition and prevention of chronic diseases</article-title>
          <source>Diabetes Obes Metab</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>354</fpage>
          <issue>5</issue>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Holt</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Newman TB,    Browner WS, Cummings SR. Delineando estudos de testes m&#233;dicos. In: Hulley    SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB. Delineando a pesquisa    cl&#237;nica: uma abordagem epidemiol&#243;gica. Porto Alegre: Artmed; 2006.    p. 203-19.</mixed-citation>
        <element-citation publication-type="book">
          <source>Delineando a pesquisa cl&#237;nica: uma abordagem epidemiol&#243;gica</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>203</fpage>
          <lpage>19</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Newman</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Browner</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Hulley</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Browner</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Grady</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hearst</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>TB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Perloff D,    Grim C, Flack J, Frohlich ED, Hill M, McDonald M, et al. Human blood pressure    determination by sphygmomanometry. Circulation. 1993; 88: 2460-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Human blood pressure determination by sphygmomanometry</article-title>
          <source>Circulation</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>2460</fpage>
          <lpage>70</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Perloff</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Grim</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Flack</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Frohlich</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation>16. Sociedade Brasileira de Cardiologia. Sociedade Brasileira de Hipertens&#227;o. V Diretrizes brasileiras de hipertens&#227;o arterial. [Acesso em 2008 fev. 20]. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.sbh.org.br/documentos/index.asp">www.sbh.org.br/documentos/index.asp</ext-link>.</mixed-citation>
        <element-citation publication-type="book">
          <source>V Diretrizes brasileiras de hipertens&#227;o arterial</source>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Janssen I,    Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk.    Arch Intern Med. 2002; 162: 2074-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Body mass index, waist circumference, and health risk</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>2074</fpage>
          <lpage>9</lpage>
          <volume>162</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Janssen</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Katzmarzyk</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Sociedade Brasileira    de Cardiologia. IV Diretriz brasileira sobre dislipidemias e preven&#231;&#227;o    da aterosclerose. Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia.    Arq Bras Cardiol. 2007; 88 (supl 1): 1-19.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>IV Diretriz brasileira sobre dislipidemias e preven&#231;&#227;o da aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1</fpage>
          <lpage>19</lpage>
          <volume>88</volume>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Barros JDA,    Hirakata VN. Alternatives for logistic regression in cross-sectional studies:    an empirical comparison of models that directly estimate the prevalence ratio.    BMC Med Res Methodol. 2003; 3: 21.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio</article-title>
          <source>BMC Med Res Methodol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>21</fpage>
          <volume>3</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Barros</surname>
              <given-names>JDA</given-names>
            </name>
            <name>
              <surname>Hirakata</surname>
              <given-names>VN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Oh JY, Hong    YS, Sung YA, Barrett-Connor E. Prevalence and factor analysis of metabolic syndrome    in an urban Korean population. Diabetes Care. 2004; 27 (8): 2027-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence and factor analysis of metabolic syndrome in an urban Korean population</article-title>
          <source>Diabetes Care</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>2027</fpage>
          <lpage>32</lpage>
          <issue>8</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Oh</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>YA</given-names>
            </name>
            <name>
              <surname>Barrett-Connor</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Santos AC,    Lopes C, Barros H. Prevalence of metabolic syndrome in the city of Porto. Rev    Port Cardiol. 2004; 23 (1): 45-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of metabolic syndrome in the city of Porto</article-title>
          <source>Rev Port Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>45</fpage>
          <lpage>52</lpage>
          <issue>1</issue>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Hwang LC, Bai    CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos    Med Assoc. 2006; 105 (8): 626-35.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of obesity and metabolic syndrome in Taiwan</article-title>
          <source>J Formos Med Assoc</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>626</fpage>
          <lpage>35</lpage>
          <issue>8</issue>
          <volume>105</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hwang</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Ford ES. Prevalence    of the metabolic syndrome defined by the International Diabetes Federation among    adults in the U.S. Diabetes Care. 2005; 28 (11): 2745-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U: S</article-title>
          <source>Diabetes Care</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2745</fpage>
          <lpage>9</lpage>
          <issue>11</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ford</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Jeppesen J,    Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S. Insulin resistance,    the metabolic syndrome, and risk of incident cardiovascular disease: a population-based    study. J Am Coll Cardiol. 2007; 49: 2112-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2112</fpage>
          <lpage>9</lpage>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jeppesen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Rasmussen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ibsen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Torp-Pedersen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Madsbad</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Mujica V, Leiva    E, Icaza G, Diaz N, Arredondo M, Carrasco RM, et al. Evaluation of metabolic    syndrome in adults of Talca city, Chile. Nutr J. 2008; 7 (14): 1-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluation of metabolic syndrome in adults of Talca city, Chile</article-title>
          <source>Nutr J</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1</fpage>
          <lpage>6</lpage>
          <issue>14</issue>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mujica</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Leiva</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Icaza</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Diaz</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Arredondo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Carrasco</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Gonzaga MLC.    Preval&#234;ncia de s&#237;ndrome metab&#243;lica nos funcion&#225;rios    do Hospital Universit&#225;rio da UFSC. [Monografia]. Florian&#243;polis:    Universidade Federal de Santa Catarina; 2006.</mixed-citation>
        <element-citation publication-type="book">
          <source>Preval&#234;ncia de s&#237;ndrome metab&#243;lica nos funcion&#225;rios do Hospital Universit&#225;rio da UFSC</source>
          <date>
            <year>2006</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Gonzaga</surname>
              <given-names>MLC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Salaroli LB,    Barbosa GC, Mill JG, Molina MCB. Preval&#234;ncia de s&#237;ndrome metab&#243;lica    em estudo de base populacional, Vit&#243;ria,ES - Brasil. Arq Bras Endocrinol    Metab. 2007; 51 (7): 1143-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preval&#234;ncia de s&#237;ndrome metab&#243;lica em estudo de base populacional, Vit&#243;ria,ES - Brasil</article-title>
          <source>Arq Bras Endocrinol Metab</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1143</fpage>
          <lpage>52</lpage>
          <issue>7</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Salaroli</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Mill</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Molina</surname>
              <given-names>MCB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Oliveira EP,    Souza MLA, Lima MDA. Preval&#234;ncia de s&#237;ndrome metab&#243;lica    em uma &#225;rea rural do semi-&#225;rido Baiano. Arq Bras Endocrinol Metab.    2006; 50 (3): 456-65.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preval&#234;ncia de s&#237;ndrome metab&#243;lica em uma &#225;rea rural do semi-&#225;rido Baiano</article-title>
          <source>Arq Bras Endocrinol Metab</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>456</fpage>
          <lpage>65</lpage>
          <issue>3</issue>
          <volume>50</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>MLA</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>MDA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Lee CMY, Huxley    RR, Woodward M, Zimmet P, Shaw J, Cho NH. Comparisons of metabolic syndrome    definitions in four populations of the Asia-Pacific region. Metab Syndr Relat    Disord. 2008; 6 (1): 37-46.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region</article-title>
          <source>Metab Syndr Relat Disord</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>37</fpage>
          <lpage>46</lpage>
          <issue>1</issue>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>CMY</given-names>
            </name>
            <name>
              <surname>Huxley</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Woodward</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zimmet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>NH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Kelliny C,    William J, Riesen W, Paccaud F, Bovet P. Metabolic syndrome according to different    definitions in a rapidly developing country of the African region. Cardiovasc    Diabetol. 2008; 7: 1-11.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Metabolic syndrome according to different definitions in a rapidly developing country of the African region</article-title>
          <source>Cardiovasc Diabetol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1</fpage>
          <lpage>11</lpage>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kelliny</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>William</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Riesen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Paccaud</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bovet</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">S&#237;ndrome metab&#243;lico en ambulatorio cardiol&#243;gico</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: En Brasil, la prevalencia de s&#237;ndrome metab&#243;lico (SM) es poco conocida en varias regiones. OBJETIVO: Analizar la prevalencia del SM, sus componentes y la concordancia entre dos criterios diagn&#243;sticos en una poblaci&#243;n con edad &gt; 13 a&#241;os. M&#201;TODOS: Estudio transversal, realizado de junio a octubre de 2007, en 719 pacientes, en ambulatorios cardiol&#243;gicos de S&#227;o Lu&#237;s, MA. Se midi&#243; la presi&#243;n arterial (PA), peso, altura, circunferencia abdominal y perfil lip&#237;dico. Se evaluaron los factores de riesgo para el SM seg&#250;n el criterio de la International Diabetes Federation (IDF). Razones de prevalencia de intervalos de confianza del 95% se estimaron por la regresi&#243;n de Poisson. RESULTADOS: La prevalencia de SM fue mayor en ambos sexos por el concepto de la IDF (62,3% en hombres y 64,6% en mujeres), con relaci&#243;n al del National Cholesterol Education Program - Adult Treatment Prevention (NCEP ATPIII) (48,9% en hombres y 59% en mujeres). Los componentes del SM m&#225;s prevalentes fueron: hipertensi&#243;n arterial sist&#233;mica - HAS (87,2% y 86%); hipertrigliceridemia (84,4% y 82,5%); circunferencia abdominal alterada (77,8% y 100%); HDL-c bajo (58,1% y 49,9%); y glucemia alterada (59,9% y 51,9%), por los conceptos NCEP ATPIII y IDF, respectivamente. Despu&#233;s del an&#225;lisis ajustado, edad &gt; 60 a&#241;os e &#237;ndice de masa corporal (IMC) &gt; 30 se asociaron a un mayor riesgo de SM (p &lt; 0,001). CONCLUSI&#211;N: La prevalencia de SM fue mucho mayor que la poblaci&#243;n general; la HAS fue el componente m&#225;s prevalente. Hubo buena concordancia entre los dos criterios, siendo &#243;ptima en el sexo femenino y regular en el masculino.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>S&#237;ndrome metab&#243;lico</kwd>
        <kwd>instituciones de asistencia ambulatoria</kwd>
        <kwd>&#233;tica</kwd>
        <kwd>cardiolog&#237;a</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>S&#237;ndrome metab&#243;lico en ambulatorio cardiol&#243;gico</bold>
          </label>
          <p>
            <bold>Jos&#233; Bonif&#225;cio Barbosa; Antonio Augusto Moura da Silva; Fabr&#237;cio de Flores Barbosa; Francisco das Chagas Monteiro J&#250;nior; Jos&#233; Albuquerque de Figueiredo Neto; Vinicius Jos&#233; da Silva Nina; Waston Gon&#231;alves Ribeiro; Eduardo Durans Figuer&#234;do; Jos&#233; Xavier de Melo Filho; Maria Beth&#226;nia da Costa Chein</bold>
          </p>
        </fn>
      </p>
      <p>Faculdade de Medicina da Universidade Federal do Maranh&#227;o (UFMA/UDI Hospital), S&#227;o Lu&#237;s, MA - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO: </bold> En Brasil, la prevalencia de s&#237;ndrome metab&#243;lico (SM) es poco conocida en varias regiones.</p>
      <p><bold>OBJETIVO: </bold> Analizar la prevalencia del SM, sus componentes y la concordancia entre dos criterios diagn&#243;sticos en una poblaci&#243;n con edad <underline>&gt;</underline> 13 a&#241;os.</p>
      <p><bold>M&#201;TODOS: </bold> Estudio transversal, realizado de junio a octubre de 2007, en 719 pacientes, en ambulatorios cardiol&#243;gicos de S&#227;o Lu&#237;s, MA. Se midi&#243; la presi&#243;n arterial (PA), peso, altura, circunferencia abdominal y perfil lip&#237;dico. Se evaluaron los factores de riesgo para el SM seg&#250;n el criterio de la <italic>International Diabetes Federation</italic> (IDF). Razones de prevalencia de intervalos de confianza del 95% se estimaron por la regresi&#243;n de Poisson.</p>
      <p><bold>RESULTADOS: </bold> La prevalencia de SM fue mayor en ambos sexos por el concepto de la IDF (62,3% en hombres y 64,6% en mujeres), con relaci&#243;n al del <italic>National Cholesterol Education Program - Adult Treatment Prevention</italic> (NCEP ATPIII) (48,9% en hombres y 59% en mujeres). Los componentes del SM m&#225;s prevalentes fueron: hipertensi&#243;n arterial sist&#233;mica - HAS (87,2% y 86%); hipertrigliceridemia (84,4% y 82,5%); circunferencia abdominal alterada (77,8% y 100%); HDL-c bajo (58,1% y 49,9%); y glucemia alterada (59,9% y 51,9%), por los conceptos NCEP ATPIII y IDF, respectivamente. Despu&#233;s del an&#225;lisis ajustado, edad <underline>&gt;</underline> 60 a&#241;os e &#237;ndice de masa corporal (IMC) <underline>&gt;</underline> 30 se asociaron a un mayor riesgo de SM (p &lt; 0,001).</p>
      <p><bold>CONCLUSI&#211;N: </bold> La prevalencia de SM fue mucho mayor que la poblaci&#243;n general; la HAS fue el componente m&#225;s prevalente. Hubo buena concordancia entre los dos criterios, siendo &#243;ptima en el sexo femenino y regular en el masculino. (Arq Bras Cardiol 2010; 94(1) : 44-51)</p>
      <p><bold>Palabras clave:</bold> S&#237;ndrome metab&#243;lico, instituciones de asistencia ambulatoria, &#233;tica, cardiolog&#237;a.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>El s&#237;ndrome metab&#243;lico (SM) consiste en la presencia de alteraciones gluc&#237;dicas (hiperinsulinemia, resistencia a la insulina, intolerancia a la glucosa o diabetes mellitus tipo 2) y lip&#237;dicas (aumento de triglic&#233;ridos y LDL-colesterol y disminuci&#243;n del HDL-colesterol), de la obesidad abdominal, de la hipertensi&#243;n arterial (HA) y de disturbios de la coagulaci&#243;n (aumento de la adhesi&#243;n plaquetaria y del inhibidor del activador del plasmin&#243;geno-PAI-1). Tambi&#233;n hay un estado proinflamatorio, con aumento de la prote&#237;na C reactiva, factor de necrosis tumoral alfa e interleuquina 6<sup>1</sup>.</p>
      <p>Hay una estrecha asociaci&#243;n de causa efecto entre el SM y las enfermedades cardiovasculares (ECV). El SM aumenta la mortalidad general en cerca de una vez y media y la cardiovascular en aproximadamente dos veces y media<sup>2</sup>. La predisposici&#243;n gen&#233;tica, alimentaci&#243;n inadecuada y sedentarismo contribuyen para su desencadenamiento<sup>3,4</sup>.</p>
      <p>En 1998, la <italic>World Health Organization</italic> (WHO) desarroll&#243; un criterio de definici&#243;n para SM incluyendo, adem&#225;s de la hipertensi&#243;n - arterial sist&#233;mica (HAS) y de la dislipidemia, la obesidad y la microalbuminuria<sup>5</sup>. En 2001, el <italic>National Institute of Health</italic>, por medio del <italic>National Cholesterol Education Program</italic> (NCEP), y el <italic>3<sup>rd</sup> Adult Treatment Panel</italic> (ATP III) sugirieron otra definici&#243;n del SM, sin incluir peso y microalbuminuria, necesitando por lo menos tres componentes anormales<sup>6</sup>.</p>
      <p>En abril de 2005, se public&#243; la primera Directriz Brasile&#241;a de Diagn&#243;stico y Tratamiento del S&#237;ndrome Metab&#243;lico, con el apoyo de la Sociedad Brasile&#241;a de Cardiolog&#237;a, que utiliz&#243; el criterio NCEP ATPIII para definir SM<sup>7</sup>. En 2006, la IDF formul&#243; una nueva definici&#243;n para SM, considerando las diferentes etnias<sup>8</sup>.</p>
      <p>El SM aumenta con la edad, en hombres y mujeres, alcanzando el 50% entre 60 y 69 a&#241;os<sup>9,10</sup>. Un estudio reciente mostr&#243; que cerca del 20% al 25% de los ni&#241;os y adolescentes obesos presentan resistencia a la insulina, elemento clave del SM y que puede llevar a la diabetes tipo 2<sup>10,11</sup>.</p>
      <p>En Ribeir&#227;o Preto, S&#227;o Paulo, un estudio de poblaci&#243;n realizado en adultos con edades entre 22 y 28 a&#241;os, publicado en 2007, mostr&#243; prevalencia del 7,6%<sup>12</sup>. Datos de la WHO muestran que en pa&#237;ses en desarrollo, la obesidad aument&#243; de dos a tres veces en la &#250;ltima d&#233;cada<sup>13</sup>.</p>
      <p>Existe un sinn&#250;mero de estudios internacionales sobre SM, siendo escasos en Brasil, raz&#243;n de inter&#233;s para estudiar esta entidad en nuestro medio, con gran heterogeneidad de factores relacionados al mismo, como los de orden demogr&#225;fico y los inherentes al estilo de vida de la poblaci&#243;n.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>Se realiz&#243; un estudio transversal - aprobado por el Comit&#233; de &#201;tica en Investigaci&#243;n del Hospital Universitario de la Universidad Federal de Maranh&#227;o -, en 719 pacientes examinados en ambulatorios de cardiolog&#237;a en la ciudad de S&#227;o Lu&#237;s (MA), entre el 1&#186; de junio y el 1&#186; de octubre de 2007, con edades entre 13 y 96 a&#241;os y edad promedio de 56,3 a&#241;os. A todos los individuos se les present&#243; un Formulario de Consentimiento Informado, firmado en caso de concordancia. Se incluyeron a todos los que comparecieron al ambulatorio de cardiolog&#237;a en el per&#237;odo mencionado, excepto los de edad inferior a 13 a&#241;os, los que no ten&#237;an ex&#225;menes de laboratorio y los que se negaron a hacerlos, gestantes y pacientes con ascitis. A todos los individuos se les aplic&#243; una ficha protocolo conteniendo: nombre, sexo, edad, color de piel, escolaridad, profesi&#243;n, ingreso familiar, antecedentes de morbilidad personal, actividad f&#237;sica, tabaquismo, alcoholismo, medida de la presi&#243;n arterial (PA), circunferencia abdominal, altura, peso, &#237;ndice de masa corporal (IMC), glucemia en ayunas, triglic&#233;ridos (TG), colesterol total (CT), HDL-colesterol y LDL-colesterol.</p>
      <p>El concepto de SM se defini&#243; seg&#250;n las directrices del NCEP ATP III y del IDF<sup>6,7</sup>, tomando en consideraci&#243;n los siguientes factores de riesgo: circunferencia abdominal, TG, HDL-c, PA y glucemia en ayunas. El diagn&#243;stico de SM por el NCEP ATPIII consiste en la alteraci&#243;n de tres de los factores antes mencionados, mientras que por la IDF el mismo se realiza por el aumento de la circunferencia abdominal m&#225;s otros dos factores de riesgo. Tanto por el concepto del NCEP como por el de la IDF, los valores alterados de los TG (<underline>&gt;</underline> 150 ml/dL), PA (<underline>&gt;</underline> 130/85 mmHg) y HDL-c (&lt; 40 para hombres y &lt; 50 para mujeres) son los mismos. La circunferencia abdominal alterada por el NCEP ATPIII es <underline>&gt;</underline> 102 cm para hombres y <underline>&gt;</underline> 88 cm para mujeres, mientras que por la IDF los valores son <underline>&gt;</underline> 90 cm para hombres y <underline>&gt;</underline> 80 cm para mujeres, valores &#233;stos propuestos para pueblos sudamericanos. El valor de glucemia en ayunas alterada en ambos conceptos, NCEP e IDF, fue considerado <underline>&gt;</underline> 100mg/dl. Se evalu&#243; tambi&#233;n la relaci&#243;n TG/HDL-c alterada <underline>&gt;</underline> 3,5. Por el &#237;ndice Kappa de Cohen<sup>14</sup> se evalu&#243; la concordancia en el diagn&#243;stico de SM por los dos criterios.</p>
      <p>La medida de la PA se realiz&#243; por el m&#233;todo indirecto con t&#233;cnica de auscultaci&#243;n y esfigmoman&#243;metros aneroides calibrados. El manguito se seleccion&#243; adecu&#225;ndolo al brazo y colocado sin dejarlo flojo, cerca de 2 a 3 cent&#237;metros por encima de la fosa cubital. El nivel de la presi&#243;n sist&#243;lica se estim&#243; palpando el pulso radial e inflando el manguito hasta su desaparici&#243;n. Despu&#233;s de inflar r&#225;pidamente y aguardar un minuto, se coloc&#243; la camp&#225;nula del estetoscopio sobre la arteria braquial. El manguito se infl&#243; r&#225;pidamente hasta superar en 20 a 30 mmHg el nivel estimado de la presi&#243;n sist&#243;lica. La deflaci&#243;n se realiz&#243; lentamente (velocidad de 2 a 4 mmHg por segundo) determinando la presi&#243;n sist&#243;lica por la ausculta del primer sonido (fase I de Korotkoff) y la diast&#243;lica por la desaparici&#243;n del sonido (fase V de Korotkoff). Los pacientes no deb&#237;an haber practicado ejercicio f&#237;sico de 60 a 90 minutos antes de la evaluaci&#243;n, ni ingerido bebidas alcoh&#243;licas o caf&#233;, o fumado 30 minutos antes de la toma de la presi&#243;n arterial. Los individuos se encontraban sentados, durante por lo menos cinco minutos en reposo, en ambiente calmo, sin ropa en el miembro superior derecho, manteniendo las piernas descruzadas, los pies apoyados en el piso, el dorso recostado en la silla y relajado, con el brazo apoyado a la altura del coraz&#243;n, con la palma de la mano dirigida hacia arriba y el codo ligeramente flexionado, sin hablar durante el procedimiento. La medida se realiz&#243; en dos momentos diferentes, con intervalo de aproximadamente dos minutos. El nivel m&#225;s bajo se consider&#243; la medida de la PA<sup>15</sup>. Se clasificaron como hipertensos pacientes con presi&#243;n arterial sist&#243;lica (PAS) <underline>&gt;</underline> 140 mmHg y/o presi&#243;n arterial diast&#243;lica (PAD) <underline>&gt;</underline> 90 mmHg, o en de antihipertensivos<sup>16</sup>.</p>
      <p>El peso corporal se obtuvo con balanza electr&#243;nica (precisi&#243;n de 0,1 kg) con la vejiga vac&#237;a y los individuos llevando s&#243;lo ropa interior. La estatura se determin&#243; con estad&#237;metro de balanza, con el individuo descalzo y con precisi&#243;n de 0,5 cm. Se calcul&#243; el IMC (IMC = Peso/Estatura), de acuerdo con la recomendaci&#243;n de la Organizaci&#243;n Mundial de la Salud (OMS) para la evaluaci&#243;n del estado nutricional<sup>13</sup>. Se utilizaron los siguientes puntos de corte para la clasificaci&#243;n de los individuos con relaci&#243;n al IMC (kg/m<sup>2</sup>): normal &lt; 25; sobrepeso de 25 a 29,99 y obeso <underline>&gt;</underline> 30. Se consider&#243; exceso de peso cuando este &#237;ndice era <underline>&gt;</underline> 25kg/m&#178;. La medici&#243;n de la circunferencia abdominal se realiz&#243; en el punto medio entre la cresta il&#237;aca y la cara externa de la &#250;ltima costilla, con cinta m&#233;trica inel&#225;stica, en posici&#243;n ortost&#225;tica, con el paciente de pie, sin ropa en el t&#243;rax, y al final de la expiraci&#243;n<sup>17</sup>.</p>
      <p>Los ex&#225;menes bioqu&#237;micos se realizaron en aparato ADVIA 1650. La concentraci&#243;n de LDL-c se calcul&#243; por la f&#243;rmula de Friedwald<sup>18</sup>.</p>
      <p>Se consideraron tabaquistas a los que consum&#237;an cigarrillos, independientemente de la cantidad de cigarrillos en el per&#237;odo de realizaci&#243;n de la investigaci&#243;n. No se consideraron los tabaquistas pasivos.</p>
      <p>El uso de alcohol fue considerado en personas que beb&#237;an independientemente del tipo y de la cantidad.</p>
      <p>Se consideraron sedentarios a los pacientes que no realizaban actividad f&#237;sica por lo menos tres veces por semana, durante treinta minutos por d&#237;a<sup>8</sup>.</p>
      <p>El grupo control estaba constituido por individuos sin SM por ambos criterios, NCEP ATPIII e IDF.</p>
      <p>Los an&#225;lisis estad&#237;sticos se realizaron en el Stata 9.0. En la evaluaci&#243;n de la asociaci&#243;n entre los factores de riesgo estudiados y la prevalencia de SM, seg&#250;n el criterio de IDF, se emple&#243; el modelo de regresi&#243;n de Poisson<sup>18</sup>. Estudios demuestran que cuando la prevalencia del evento es superior al 10%, el uso del modelo de regresi&#243;n log&#237;stica para la estimaci&#243;n del <italic>odds ratio</italic> promueve una superestimaci&#243;n del riesgo. Se calcularon las razones de prevalencia por el m&#233;todo robusto y su respectivo intervalo de confianza del 95%. El nivel de significancia adoptado fue el 5%. Todas las variables que presentaron p &lt; 0,20 en el an&#225;lisis no ajustado fueron seleccionadas para el an&#225;lisis multivariable. En el an&#225;lisis ajustado se utiliz&#243; el m&#233;todo de selecci&#243;n de variables por pasos (<italic>stepwise)</italic> con eliminaci&#243;n retr&#243;grada. S&#243;lo quedaron en el modelo final aquellas variables asociadas a un valor de P &lt; 0,10<sup>19</sup>.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Las caracter&#237;sticas basales de los individuos estudiados en ambulatorio de cardiolog&#237;a se resumen en la <xref ref-type="table" rid="es_09t01-body2">Tabla 1</xref>. La edad promedio de los hombres fue de 56 a&#241;os y de las mujeres, 58 a&#241;os. Entre los antecedentes de morbilidad personales - insuficiencia coronaria (ICo), accidente vascular cerebral (AVC), enfermedad vascular perif&#233;rica (EVP), diabetes mellitus (DM) y HAS -, s&#243;lo la ICo fue diferente seg&#250;n el sexo, con el 23,4% entre los hombres, contra el 13,9% entre las mujeres (p &lt; 0,001). La prevalencia del SM fue mayor en ambos sexos por el concepto de la IDF (62,3% para hombres y 64,6% para mujeres), cuando se la compara con el del NCEP (48,9% para hombres y 59% para mujeres). Entre las variables lip&#237;dicas, los promedios del CT (194 mg/dl), del HDL-c (51 mg/dl) y del LDL-c (118 mg/dl) fueron m&#225;s elevadas entre las mujeres que entre los hombres (CT 183 mg/dl, HDL-c 44 mg/dl y LDL-c 108,5 mg/dl). Los promedios de los TG (141 mg/dl) y de la relaci&#243;n CT/HDL (4,1) fueron mayores entre los hombres con relaci&#243;n a las mujeres, TG (120 mg/dl) y CT/HDL (-3,8). Los promedios de los TG (141 mg/dl) y de la relaci&#243;n TG/HDL-c <underline>&gt;</underline> 3,8 (38,3) fueron mayores entre los hombres con relaci&#243;n a las mujeres, TG (120 mg/dl) y TG/HDL-c (19,2). En el sexo masculino hubo un 30,7% de HDL-c bajo con relaci&#243;n al 42,6% en el sexo femenino, mientras que el 68,7% de los hombres presentaron hipertrigliceridemia contra el 54,6% de las mujeres. Obesidad, variables hemodin&#225;micas, tabaquismo y actividad f&#237;sica no tuvieron diferencia estad&#237;sticamente significativa entre hombres y mujeres. El uso de alcohol fue significativamente mayor entre los hombres (49,2%) que entre las mujeres (19,5%).</p>
      <p content-type="asset">
        <table-wrap id="es_09t01-body2">
          <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt01-es.jpg"/></table-wrap>
      </p>
      <p>La <xref ref-type="table" rid="es_09t02-body2">Tabla 2</xref> describe las caracter&#237;sticas de los individuos estudiados de acuerdo con las definiciones de SM por el NCEP e IDF. Entre los 719 individuos evaluados, 243 no ten&#237;an SM, 391 individuos ten&#237;an por lo menos el concepto del NCEP y 457 por el de la IDF. Individuos con SM por los dos conceptos eran m&#225;s viejos, ten&#237;an m&#225;s antecedentes de morbilidad personales (DM, HAS y ICo), glucemia en ayunas alterada y variables lip&#237;dicas alteradas (HDL-c m&#225;s bajo, LDL-c m&#225;s alto, relaci&#243;n CT/HDL-c m&#225;s elevada, hipertrigliceridemia, relaci&#243;n TG/HDL-c <underline>&gt;</underline> 3,8). Tambi&#233;n eran m&#225;s pesados y m&#225;s bajos, con IMC, circunferencia de la cintura y presi&#243;n arterial sist&#243;lica y diast&#243;lica m&#225;s elevadas. Ten&#237;an m&#225;s obesidad, exceso de peso, circunferencia de la cintura alterada e hipertensi&#243;n. Comparando los individuos con y sin SM, no fueron diferentes los antecedentes de morbilidad personales (AVC y EVP), colesterol total y las variables de estilo de vida (tabaquismo, consumo de alcohol y actividad f&#237;sica).</p>
      <p content-type="asset">
        <table-wrap id="es_09t02-body2">
          <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt02-es.jpg"/></table-wrap>
      </p>
      <p>La concordancia general medida por el Kappa fue de 0,70, p &lt; 0,001. En el sexo femenino, el valor del Kappa fue 0,82 (p &lt; 0,001) y en el masculino fue 0,58 (p &lt; 0,001).</p>
      <p>La <xref ref-type="table" rid="es_09t03-body2">Tabla 3</xref> muestra el an&#225;lisis no ajustado de los factores de riesgo para SM por el criterio de la IDF. Pacientes con edad <underline>&gt;</underline> 40 a&#241;os, escolaridad <underline>&lt;</underline> 8 a&#241;os de estudio, Ingreso familiar <underline>&lt;</underline> 1.000 reales, que viv&#237;an con compa&#241;ero (casados o en uni&#243;n consensual) y sobrepeso y/u obesidad tuvieron mayor riesgo de SM.</p>
      <p content-type="asset">
        <table-wrap id="es_09t03-body2">
          <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt03-es.jpg"/></table-wrap>
      </p>
      <p>La <xref ref-type="table" rid="t4-body2">Tabla 4</xref> muestra el an&#225;lisis ajustado de los factores de riesgo para SM por el criterio de la IDF. Tuvo significancia estad&#237;stica edad <underline>&gt;</underline> 60 a&#241;os e IMC <underline>&gt;</underline> 30.</p>
      <table-wrap id="t4-body2">
        <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt04-es.jpg"/></table-wrap>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>Se utilizaron en este estudio, dos conceptos para definici&#243;n del SM, el del NCEP ATPIII (I Directriz Brasile&#241;a de Diagn&#243;stico y Tratamiento del S&#237;ndrome Metab&#243;lico) y el de la IDF, evaluando a 719 individuos en ambulatorio de cardiolog&#237;a. La prevalencia del SM fue del 54,4% (391 casos) seg&#250;n el NCEP y del 63,6% (457 casos) de acuerdo con el IDF, siendo m&#225;s prevalente en el sexo femenino. Los componentes del SM m&#225;s prevalentes fueron: HAS, hipertrigliceridemia y circunferencia abdominal alterada, seguidos de HDL-c bajo y glucemia alterada. Entre las comorbilidades asociadas, la ICo y el AVC fueron las m&#225;s presentes. El SM fue m&#225;s prevalente entre los individuos de bajos ingresos y de edad m&#225;s elevada. El tabaquismo, consumo de alcohol y actividad f&#237;sica no estuvieron significativamente asociados al SM. Despu&#233;s del an&#225;lisis ajustado de los factores de riesgo para SM, por el criterio de la IDF, edad <underline>&gt;</underline> 60 a&#241;os e IMC <underline>&gt;</underline> 30 fueron los que estuvieron significativamente asociados a un mayor riesgo de SM.</p>
      <p>
        <bold>Prevalencia de s&#237;ndrome metab&#243;lico general y seg&#250;n el sexo</bold>
      </p>
      <p>En un estudio en la poblaci&#243;n urbana de Corea, en individuos con edad de 30 a 80 a&#241;os, por el criterio del NCEP ATP III, la prevalencia del SM fue del 16% en hombres y del 10,7% en mujeres<sup>20</sup>. Ya por la IDF, la prevalencia fue del 29% en hombres y del 16,8% en mujeres. En la ciudad de Porto, en Portugal<sup>21</sup>, un estudio con 1.436 adultos (hombres y mujeres) mostr&#243; prevalencia de SM del 23,9% (27% en mujeres y 19,1% en hombres) por el criterio del NCEP ATPIII. En Taiw&#225;n, en 5.936 individuos con edades entre 20 y 79,9 a&#241;os, la prevalencia de SM fue del 15,7% por el concepto del NCEP ATPIII y del 14,3% por el de la IDF<sup>22</sup>. En un estudio realizado en los Estados Unidos<sup>23</sup>, con 3. 601 participantes con edades variante entre 20 y 70 a&#241;os, la prevalencia de SM fue del 34,5% por el concepto del NCEP ATPIII (33,7% entre los hombres y 35,4% entre las mujeres), y del 39,% por el IDF (39,9% en los hombres y 38,1% en las mujeres). En Dinamarca<sup>24</sup>, un estudio entre 2.493 individuos, con edades entre 41 y 72 a&#241;os, mostr&#243; prevalencia del 21% (17,5% para hombres y 23,8% para mujeres) por la IDF y del 16% (14,3% para hombres y 18,6% para mujeres) por el NCEP ATPIII. En 2007, 1.007 individuos fueron evaluados en Talca, Chile, con edades de 18 a 74 a&#241;os<sup>25</sup>, mostrando prevalencia del SM por los conceptos del NCEP ATPIII e IDF del 36,4% y del 29,5%, respectivamente.</p>
      <p>En el <italic>Hospital Universit&#225;rio de Santa Catarina</italic><sup>26</sup>, por el concepto de la IDF, la prevalencia del SM fue del 21,9% en el sexo femenino y del 19,4% en el masculino. En Vit&#243;ria, Esp&#237;rito Santo<sup>27</sup>, por el NCEP ATPIII, la prevalencia de SM en 1.663 individuos con edades entre 25 y 64 a&#241;os fue del 29,8%. En un &#225;rea rural del semi&#225;rido bahiano, se estudiaron a 240 individuos con edad <underline>&gt;</underline> 25 a&#241;os<sup>28</sup> y, por el criterio del NCEP ATPIII, la prevalencia del SM fue del 30% (38,4% en mujeres y 18,6% en hombres).</p>
      <p>En este estudio, la prevalencia de Sm, el 54,4% seg&#250;n el NCEP y el 63,6% de acuerdo con el IDF, fue m&#225;s elevada que en los estudios antes citados, pues la muestra aqu&#237; estudiada estaba formada por pacientes atendidos en ambulatorio de cardiolog&#237;a, la mayor&#237;a con enfermedades cardiovasculares. Hubo mayor prevalencia del SM en el sexo femenino como en los estudios de Dinamarca<sup>24</sup>, Santa Catarina<sup>26</sup> y de la ciudad de Porto<sup>21</sup>, diferente de los estudios de Corea<sup>20</sup>, Estados Unidos de Am&#233;rica<sup>24</sup> y Talca (Chile)<sup>25</sup>, en los cuales la prevalencia fue mayor en el sexo masculino.</p>
      <p>
        <bold>Prevalencia de los componentes del s&#237;ndrome metab&#243;lico</bold>
      </p>
      <p>Un estudio dinamarqu&#233;s<sup>24</sup> mostr&#243; mayor prevalencia de los componentes del SM: obesidad (38,6%), HDL-c bajo (37,1%) y HAS (34%), mientras que en este estudio prevalecieron: HAS (87,2%), hipertrigliceridemia (84,4%) y HDL-c bajo (58,1%), por el concepto del NCEP ATP III. Los niveles de CT, LDL-c y los niveles de TG fueron m&#225;s elevados en el estudio de Dinamarca<sup>24</sup>, mientras que los niveles de HDL-c bajo fueron m&#225;s altos en este estudio. La relaci&#243;n CT/HDL-c fue mayor en el estudio dinamarqu&#233;s (NCEP ATPIII), similar al observado en este trabajo. La presencia del 27,7% de DM en este estudio fue mucho mayor que el 7% relatado en el trabajo dinamarqu&#233;s<sup>24</sup>.</p>
      <p>El consumo de alcohol y la actividad f&#237;sica fueron m&#225;s prevalentes en este estudio, al contrario del tabaquismo, m&#225;s frecuente en el trabajo dinamarqu&#233;s<sup>24</sup> (44% contra 7,4%).</p>
      <p>En un estudio en el semi&#225;rido bahiano<sup>28</sup>, el HDL-c bajo (70,4%) y la elevaci&#243;n de la PA (57,1%) fueron los componentes del SM m&#225;s prevalentes, mientras que en este estudio fueron: exceso de peso y obesidad (92,9%), HAS (87,2%) e hipertrigliceridemia (84,4%). En este estudio, la obesidad abdominal, exceso de peso y reducci&#243;n del HDL-c fueron m&#225;s prevalentes en el sexo masculino, al contrario de lo que ocurri&#243; en el semi&#225;rido bahiano, en que la mayor prevalencia de estos factores se observ&#243; en el sexo femenino.</p>
      <p>
        <bold>Concordancia entre las dos definiciones de s&#237;ndrome metab&#243;lico</bold>
      </p>
      <p>La concordancia general, medida por el kappa, fue considerada buena, indicando que ambos criterios pueden ser utilizados en la pr&#225;ctica cl&#237;nica. La concordancia fue &#243;ptima en el sexo femenino y regular en el sexo masculino, sugiriendo que los criterios actualmente utilizados no est&#225;n muy adecuados para el sexo masculino (concordancia regular).</p>
      <p>Posiblemente, la menor concordancia en el diagn&#243;stico de SM entre los dos criterios en el sexo masculino se deriv&#243; del criterio utilizado para caracterizar circunferencia de la cintura alterada. Por el criterio de la IDF, no hay diferencia en la prevalencia de circunferencia de la cintura alterada entre los sexos, mientras que por el NCEP ATPIII, hay diferencia, pues el 64,6% y de las mujeres y el 43,8% de los hombres tienen circunferencia de la cintura alterada. Ello sugiere que el criterio de diagn&#243;stico de circunferencia de la cintura alterada utilizado por el NCEP ATPIII para hombres tal vez sea inadecuado y haya sido el responsable por la baja concordancia observada.</p>
      <p>Los datos de este estudio son similares a los encontrados por Cristal Lee et al, en un trabajo con 22.403 individuos y edad <underline>&gt;</underline> 35 a&#241;os, que muestran una &#243;ptima concordancia para mujeres entre los dos conceptos<sup>29</sup>. Clara Kelliny et al<sup>30</sup>, en un trabajo con 1.218 individuos con edad promedio de 42 a&#241;os, mostraron concordancia general de 0,82 entre los conceptos<sup>30</sup>.</p>
      <p>
        <bold>Factores asociados al s&#237;ndrome metab&#243;lico</bold>
      </p>
      <p>En este estudio, la obesidad (IMC <underline>&gt;</underline> 30kg/m&#178;), despu&#233;s del an&#225;lisis ajustado de los factores de riesgo, estuvo significativamente asociada al SM. Este resultado fue observado en otros estudios, como EEUU<sup>23</sup>, Chile<sup>25</sup>, as&#237; como en Brasil, en el estudio de Vit&#243;ria (ES)<sup>27</sup> y del semi&#225;rido bahiano<sup>28</sup>. Posiblemente este hecho haya ocurrido por la reducci&#243;n de actividad f&#237;sica y aumento de la ingesta de grandes cantidades de calor&#237;as en esas poblaciones.</p>
      <p>Entre los americanos<sup>23</sup>, la prevalencia de SM fue mayor en los individuos de mayores ingresos, al contrario de este estudio, en el cual la prevalencia fue m&#225;s elevada en personas con menores ingresos. El tabaquismo y el consumo de alcohol fueron independientemente asociados al SM en el trabajo americano<sup>23</sup>, lo que no ocurri&#243; en este trabajo.</p>
      <p>En este estudio, la prevalencia del SM aument&#243; con la edad, sucediendo lo mismo en los estudios realizados en el semi&#225;rido bahiano<sup>28</sup>, en Vit&#243;ria<sup>27</sup>, Talca<sup>25</sup> y en los Estados Unidos<sup>23</sup>.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>El estudio mostr&#243; que la prevalencia del SM en ambulatorio cardiol&#243;gico fue mucho mayor que la poblaci&#243;n general; la HAS fue el componente m&#225;s prevalente. Hubo buena concordancia entre los dos criterios, siendo &#243;ptima para el sexo femenino y regular para el sexo masculino.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El UDI Hospital financi&#243; el presente estudio.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de la tesis de Maestr&#237;a de Jos&#233; Bonif&#225;cio Barbosa de la Universidad Federal de Maranh&#227;o - UFMA.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Metabolic syndrome in outpatient cardiology clinics</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: In Brazil, the prevalence of the metabolic syndrome (MS) is little known in several regions. OBJECTIVE: To analyze the prevalence of MS, its components and the agreement between two diagnostic definitions in a population aged &gt; 13 years. METHODS: Cross-sectional study conducted from June to October 2007 in 719 patients of outpatient cardiology clinics in the city of S&#227;o Luis, State of Maranh&#227;o, Brazil. Blood pressure (BP), weight, height, waist circumference and lipid profile were measured. Risk factors for MS were evaluated according to the International Diabetes Federation (IDF) definition. Prevalence ratios and 95% confidence intervals were estimated using Poisson regression. RESULTS: The prevalence of MS was higher in both genders when using IDF definition (62.3% in men and 64.6% in women) than when using that of the National Cholesterol Education Program - Adult Treatment Prevention (NCEP ATPIII) (48.9% in men and 59% in women). The most prevalent MS components were: hypertension (87.2% and 86%); hypertriglyceridemia (84.4% and 82.5%); increased waist circumference (77.8% and 100%); low HDL-c (58.1% and 49.9%); and high blood glucose (59.9% and 51.9%), using NCEP ATPIII and IDF definitions, respectively. In the adjusted analysis, age &gt; 60 years and body mass index (BMI) &gt; 30 were associated with a higher risk of MS (p&lt;0.001). CONCLUSION: The prevalence of MS was much higher than in the overall population, and hypertension was the most prevalent component. There was good agreement between the two definitions, very good in the female gender and moderate in the male gender.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Metabolic syndrome</kwd>
        <kwd>ambulatory care facilities</kwd>
        <kwd>ethic</kwd>
        <kwd>cardiology</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Metabolic syndrome in outpatient cardiology clinics</bold>
          </label>
          <p>
            <bold>Jos&#233; Bonif&#225;cio Barbosa; Antonio Augusto Moura da Silva; Fabr&#237;cio de Flores Barbosa; Francisco das Chagas Monteiro J&#250;nior; Jos&#233; Albuquerque de Figueiredo Neto; Vinicius Jos&#233; da Silva Nina; Waston Gon&#231;alves Ribeiro; Eduardo Durans Figuer&#234;do; Jos&#233; Xavier de Melo Filho; Maria Beth&#226;nia da Costa Chein</bold>
          </p>
        </fn>
      </p>
      <p>Faculdade de Medicina da Universidade Federal do Maranh&#227;o (UFMA/UDI Hospital), S&#227;o Lu&#237;s, MA - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> In Brazil, the prevalence of the metabolic syndrome (MS) is little known in several regions.</p>
      <p><bold>OBJECTIVE: </bold> To analyze the prevalence of MS, its components and the agreement between two diagnostic definitions in a population aged &gt; 13 years.</p>
      <p><bold>METHODS: </bold> Cross-sectional study conducted from June to October 2007 in 719 patients of outpatient cardiology clinics in the city of S&#227;o Luis, State of Maranh&#227;o, Brazil. Blood pressure (BP), weight, height, waist circumference and lipid profile were measured. Risk factors for MS were evaluated according to the International Diabetes Federation (IDF) definition. Prevalence ratios and 95% confidence intervals were estimated using Poisson regression.</p>
      <p><bold>RESULTS: </bold> The prevalence of MS was higher in both genders when using IDF definition (62.3% in men and 64.6% in women) than when using that of the National Cholesterol Education Program - Adult Treatment Prevention (NCEP ATPIII) (48.9% in men and 59% in women). The most prevalent MS components were: hypertension (87.2% and 86%); hypertriglyceridemia (84.4% and 82.5%); increased waist circumference (77.8% and 100%); low HDL-c (58.1% and 49.9%); and high blood glucose (59.9% and 51.9%), using NCEP ATPIII and IDF definitions, respectively. In the adjusted analysis, age <underline>&gt;</underline> 60 years and body mass index (BMI) <underline>&gt;</underline> 30 were associated with a higher risk of MS (p&lt;0.001).</p>
      <p><bold>CONCLUSION: </bold> The prevalence of MS was much higher than in the overall population, and hypertension was the most prevalent component. There was good agreement between the two definitions, very good in the female gender and moderate in the male gender.</p>
      <p><bold>Key-Words:</bold> Metabolic syndrome; ambulatory care facilities; ethic; cardiology.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>The metabolic syndrome (MS) consists of the presence of glucose changes (hyperinsulinemia, insulin resistance, glucose intolerance, or type-2 diabetes mellitus), lipid changes (increased triglycerides and LDL-cholesterol and decreased HDL-cholesterol), abdominal obesity, hypertension, and coagulation disorders (increased platelet adhesion and PAI-1-plasminogen activator inhibitor). A proinflammatory state is also observed, with increased C-reactive protein, tumor necrosis factor alpha and interleukin-6<sup>1</sup>.</p>
      <p>There is a close cause-effect relationship between MS and cardiovascular diseases (CVDs). MS increases overall mortality by approximately one and a half times, and cardiovascular mortality by approximately two and a half times<sup>2</sup>. Genetic predisposition, inappropriate eating and sedentary lifestyle contribute to its development<sup>3,4</sup>.</p>
      <p>In 1998, the World Health Organization (WHO) developed criteria for the definition of MS, including obesity and microalbuminuria in addition to hypertension and dyslipidemia<sup>5</sup>. In 2001, the National Institutes of Health, by means of the National Cholesterol Education Program (NCEP) and the Third Adult Treatment Panel (ATP III) suggested another definition for MS, without including weight and microalbuminuria, and requiring at least three abnormal components<sup>6</sup>.</p>
      <p>In April 2005, the first Brazilian Guideline on the Diagnosis and Treatment of The metabolic Syndrome was published with the support of the Brazilian Society of Cardiology, using NCEP ATPIII criteria to define MS<sup>7</sup>. In 2006, IDF formulated a new definition for MS, considering the different ethnic populations<sup>8</sup>.</p>
      <p>The incidence of MS increases with age, both in men and women, reaching 50% among those aged 60 to 69 years<sup>9,10</sup>. A recent study showed that 20% to 25% of obese children and adolescents present insulin resistance, a key element of MS that can lead to type-2 diabetes<sup>10,11</sup>.</p>
      <p>In the city of Ribeir&#227;o Preto - State of Sao Paulo, a population survey conducted among adults aged between 22 and 28 years, and published in 2007, showed a 7.6% prevalence<sup>12</sup>. Data from the WHO show that, in developing countries, the frequency of obesity has increased two to three fold in the past decade<sup>13</sup>.</p>
      <p>Innumerous international but few Brazilian studies on MS are available, and this is the reason for the interest in studying this entity in our midst, where we observe a marked heterogeneity of factors related to MS, such as demographic factors and those inherent to the lifestyle of the population</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>This is a cross-sectional study including 719 patients seen in outpatient cardiology clinics of the city of S&#227;o Lu&#237;s - State of Maranh&#227;o and conducted between June 1st and October 1st, 2007. The patients were aged between 13 and 96 years, with mean of 56.3 years. The study was approved by the Research Ethics Committee of <italic>Hospital Universit&#225;rio da Universidade Federal do Maranh&#227;o</italic>. All individuals who agreed to participate gave their written informed consent. All patients who attended the outpatient cardiology clinics during the period mentioned were included, except for those younger than 13 years, those lacking laboratory tests or who refused to undergo them, pregnant women, and patients with ascites. A protocol form was completed for all subjects, containing data on name; gender; age; skin color; level of educational attainment; profession; family income; past medical history; physical activity; smoking; alcohol consumption; blood pressure (BP) measurement; waist circumference; height; weight; body mass index (BMI); fasting blood glucose; triglycerides (TG); total cholesterol (TC); HDL-cholesterol; and LDL-cholesterol.</p>
      <p>The concept of MS was defined according to the NCEP ATP III and IDF guidelines<sup>6,7</sup> taking the following risk factors into consideration: waist circumference, TC, HDL-c, BP, and fasting blood glucose. The diagnosis of MS according to the NCEP ATPIII consists of the alteration of three of the factors mentioned above, whereas according to IDF the diagnosis is made when increased waist circumference is present plus at least two other risk factors. Both the NCEP and the IDF use the same parameters to define abnormal values of TG (<underline>&gt;</underline> 150mL/dL), BP (<underline>&gt;</underline> 130/85 mmHg) and HDL-c (&lt; 40 for men and &lt; 50 for women). Abnormal values of waist circumference adopted by the NCEP ATPIII are <underline>&gt;</underline> 102cm for men and <underline>&gt;</underline> 88cm for women, whereas those adopted by IDF are <underline>&gt;</underline> 90cm for men and <underline>&gt;</underline> 80 cm for women; these values have been proposed for South-American peoples. Abnormal fasting blood glucose levels for both NCEP and IDF were those <underline>&gt;</underline> 100mg/dl. The TG/HDL-c ratio was also assessed, with values <underline>&gt;</underline> 3.5 considered abnormal. Agreement in the diagnosis of MS based on the two definitions was assessed using the Cohen's kappa coefficient<sup>14</sup>.</p>
      <p>BP was measured using the indirect method with the auscultatory technique and calibrated aneroid sphygmomanometers. Cuffs adequate to the arm size were selected and fastened tight at approximately 2 to 3 centimeters above the cubital fossa. Systolic blood pressure level was estimated by palpating the radial pulse and inflating the cuff until it disappeared. After rapid inflation and one-minute interval, the stethoscope bell was placed over the brachial artery. The cuff was rapidly inflated to 20 to 30 mmHg above the estimated systolic blood pressure level. Deflation was slow (rate of 2 to 4 mmHg per second), and the systolic blood pressure was determined by the auscultation of the first sound (Korotkoff phase I); diastolic blood pressure was determined when the sounds disappeared (Korotkoff phase V). Patients were required not to exercise 60 to 90 minutes before the assessment, drink alcoholic beverages and coffee, or smok 30 minutes before blood pressure reading. They should be seated resting for least five minutes in a quiet room, with the right arm bared, legs not crossed, feet flat on the floor, back supported by the chair and relaxed. The arm should be supported at the heart level, with the hand palm turned upwards, elbow slightly flexed. The patients were asked not to talk during the procedure. The measurements were taken at two different timepoints, with approximately two-minute interval; the lowest level found was considered as the patient's BP<sup>15</sup>. Patients with systolic blood pressure (SBP) <underline>&gt;</underline> 140 mmHg and/or diastolic blood pressure (DBP) <underline>&gt;</underline> 90 mmHg or taking antihypertensive drugs were classified as hypertensive<sup>16</sup>.</p>
      <p>Body weight was measured in an electronic scale (to the nearest 0.1kg) with the patient on an empty bladder and wearing only underwear. Height was measured on a scale stadiometer, with the individual barefoot and to the nearest 0.5 cm. BMI was calculated (BMI = Weight/Height<sup>2</sup>) according to the WHO recommendations for nutritional assessment<sup>13</sup>. The following cut-off points were used for the classification of the individuals as regards BMC (kg/m<sup>2</sup>): normal &lt; 25; overweight from 25 to 29.99; and obese <underline>&gt;</underline> 30. Indexes <underline>&gt;</underline> 25 kg/m&#178; were considered excess weight. Waist circumference was measured midway between the iliac crest and the lower costal margin, with a non-stretchable tape measure, while the individual was standing bare chest, and at end-expiration<sup>17</sup>.</p>
      <p>Biochemical tests were determined in an ADVIA 1650 instrument. LDL-c levels were calculated using Friedwald's formula<sup>18</sup>.</p>
      <p>Those who smoked cigarettes during the study period were considered smokers regardless of the amount. Second-hand smokers were not considered.</p>
      <p>Alcohol consumption was considered positive for individuals who drank alcohol regardless of type or amount of beverage.</p>
      <p>Sedentary individuals were considered those who did not engage in physical activity at least three times a week, thirty minutes per day<sup>8</sup>.</p>
      <p>The control group was comprised of individuals without MS according to both definitions - NCEP ATPIII and IDF.</p>
      <p>Statistical analysis was carried out in Stata 9.0. The Poisson's regression model was used for the analysis of the association between the risk factors studied and the prevalence of MS, according to the IDF definition<sup>18</sup>. Studies demonstrate that when the prevalence of an event is higher than 10%, the use of the logistic regression model for the estimate of the odds ratio leads to an overestimated risk. Prevalence ratios were calculated using the robust method and its respective 95% confidence interval. Significance level was set 5%. All variables presenting p &lt; 0.20 in the non-adjusted analysis were selected for multivariate analysis. The stepwise variable selection method with backward elimination was used in the adjusted analysis. Only variables associated with p &lt; 0.10 remained in the final model<sup>19</sup>.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Baseline characteristics of the subjects studied in outpatient cardiology clinics are summarized in <xref ref-type="table" rid="en_09t01-body3">Table 1</xref>. The mean age was 56 and 58 years for men and women, respectively. As regards the past medical history (coronary insufficiency - ICo, stroke, peripheral vascular disease - PVD, diabetes mellitus - DM, and hypertension), only ICo showed gender-related differences, with 23.4% among men versus 13.9% among women (p&lt; 0.001). The prevalence of MS was higher in both genders according to the IDF definition (62.3% for men and 64.6% for women), in comparison to that according to the NCEP definition (48.9% for men and 59% for women). Among the lipid variables, means of TC (194 mg/dl), HDL-c (51 mg/dl), and LDL-c (118 mg/dl) were higher among women than among men (TC 183mg/dl; HDL-c 44 mg/dl and LDL-c 108.5 mg/dl). Mean TG and TC/HDL ratio were higher among men in relation to women (mean TG= 141mg/dl and120 mg/dl; and mean TC/HDL ratio = 4.1 and -3.8, respectively). Mean TG (141 mg/dl) and mean TG/HDL-c ratio <underline>&gt;</underline> 3.8 (38.3) were higher among men in relation to women (TG = 120 mg/dl and TG/HDL-c = 19.2). Among men, there was 30.7% of low HDL-c in relation to 42.6% among women, whereas 68.7% of men had hypertriglyceridemia versus 54.6% of women. No statistically significant differences were found between men and women for obesity, hemodynamic variables, smoking and physical activity. The alcohol use was significantly more frequent among men (49.2%) than among women (19.5%).</p>
      <p content-type="asset">
        <table-wrap id="en_09t01-body3">
          <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt01-en.jpg"/></table-wrap>
      </p>
      <p>Characteristics of the subjects studied according to the NCEP and IDF definitions for MS are shown in <xref ref-type="table" rid="en_09t02-body3">Table 2</xref>. Of the 719 individuals assessed, 243 did not have MS, 391 had MS according to the NCEP definition, and 457 according to the IDF definition. Individuals with MS according to both definitions were older, had more previous diseases (DM, hypertension and ICo), abnormal fasting blood glucose and abnormal lipid variables (lower HDL-c, higher LDL-c, higher TC/HDL-c ratio, hypertriglyceridemia, TG/HDL-c ratio <underline>&gt;</underline> 3.8). They were also heavier, shorter, and had higher BMI, waist circumference, systolic and diastolic blood pressure. They also had a higher frequency of obesity, excess weight, abnormal waist circumference and hypertension. The comparison between individuals with and without MS did not show differences regarding the past medical history (stroke and PVD), total cholesterol, and variables related to lifestyle (smoking, alcohol use and physical activity).</p>
      <p content-type="asset">
        <table-wrap id="en_09t02-body3">
          <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt02-en.jpg"/></table-wrap>
      </p>
      <p>The overall agreement as measured using the Kappa statistics was 0.70, p&lt;0.001. Kappa values were 0.82 (p &lt; 0.001) in the female gender and 0.58 (p &lt; 0.001) in the male gender.</p>
      <p>The non-adjusted analysis of the risk factors for MS according to the IDF definition is shown in <xref ref-type="table" rid="en_09t03-body3">Table 3</xref>. Patients with age <underline>&gt;</underline> 40 years, educational attainment <underline>&lt;</underline> 8 years of schooling, family income <underline>&lt;</underline> 1,000 real, who lived with a partner (whether legally or otherwise), and with overweight and/or obesity had a higher risk of MS.</p>
      <p content-type="asset">
        <table-wrap id="en_09t03-body3">
          <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt03-en.jpg"/></table-wrap>
      </p>
      <p>The adjusted analysis of the risk factors for MS according to the IDF definition is shown in <xref ref-type="table" rid="t4-body3">Table 4</xref>. Statistical significance was found for age <underline>&gt;</underline> 60 years and BMI <underline>&gt;</underline> 30.</p>
      <table-wrap id="t4-body3">
        <graphic xlink:href="1678-4170-abc-94-01-0046-00009-gt04-en.jpg"/></table-wrap>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>In this study, two definitions for MS were used: NCEP ATPIII's (I Brazilian Guideline on the Diagnosis and Treatment of Metabolic Syndrome) and IDF's. A total of 719 individuals seen in outpatient cardiology clinics were assessed. The prevalence of MS was 54.4% (391 cases) according to NCEP, and 63.6% (457 cases) according to IDF, and was higher among women. The most prevalent MS components were hypertension, hypertriglyceridemia, and abnormal waist circumference, followed by low HDL-c and abnormal blood glucose. As regards comorbidities, ICo and stroke were the most frequent. MS was more prevalent among low-income and older individuals. Smoking, alcohol use and physical activity were not significantly associated with MS. After an adjusted analysis of risk factors for MS, according to the IDF definition, age <underline>&gt;</underline> 60 years and BMI <underline>&gt;</underline> 30 were those significantly associated with a higher risk of MS.</p>
      <p>
        <bold>Prevalence of metabolic syndrome, overall and by gender</bold>
      </p>
      <p>In an urban Korean population of individuals 30 to 80 years of age, the prevalence of MS using NCEP ATP III definition was 16% among men and 10.7% among women<sup>20</sup>. Using IDF, the prevalence was 29% among men and 16.8% among women. In the city of Oporto, Portugal<sup>21</sup>, a study with 1436 adults (men and women) showed a 23.9% prevalence of MS (27% in women and 19.1% in men) according to the NCEP ATPIII definition. In Taiwan, among 5,936 individuals 20 to 79.9 years of age, the prevalence of MS was 15.7% and 14.3% according to the NCEP ATPIII and IDF definitions, respectively<sup>22</sup>. In a study conducted in the United States<sup>23</sup> with 3601 participants with age ranging from 20 to 70 years, the prevalence of MS was 34.5% according to the NCEP ATPIII definition (33.7% among men and 35.4 among women) and 39% according to the IDF definition (39.9% among men and 38.1 among women). In Denmark<sup>24</sup>, a study with 2493 subjects aged between 41 and 72 years showed a 21% prevalence (17.5% for men and 23.8% for women) according to IDF and 16% (14.3% for men and 18.6% for women) according to NCEP ATPIII. In 2007, 1,007 individuals aged from 18 to 74 years were assessed in Talca, Chile<sup>25</sup>, and the prevalences of MS found according to the NCEP ATPIII and IDF definitions were 36.4% and 29.5%, respectively.</p>
      <p>In the University Hospital of Santa Catarina<sup>26</sup>, the prevalence of MS according to the IDF definition was 21.9% among women and 19.4% among men. In the city of Vit&#243;ria, State of Esp&#237;rito Santo, Brazil<sup>27</sup>, the prevalence of MS according to NCEP ATPIII in 1,663 individuals aged between 25 and 64 years was 29.8%. In a rural area in the State of Bahia, Brazil, 240 individuals with age <underline>&gt;</underline> 25 years were studied<sup>28</sup>, and according to the NCEP ATPIII definition, the prevalence of MS was 30% (38.4% in women and 18.6% in men). In the present study, the prevalence of MS, 54.4% according to NCEP and 63.6% according to IDF was higher than that found in the studies previously mentioned, because our sample was comprised of patients seen in outpatient cardiology clinics, most of them with cardiovascular diseases.</p>
      <p>In this study, we found a higher prevalence of MS in the female gender, like in the studies conducted in Denmark<sup>24</sup>, Santa Catarina<sup>26</sup>, and in the city of Oporto<sup>21</sup>, and unlike those carried out in Korea<sup>20</sup>, United States of America<sup>24</sup>, and Talca (Chile)<sup>25</sup>, where a higher prevalence was observed in the male gender.</p>
      <p>
        <bold>Prevalence of metabolic syndrome components</bold>
      </p>
      <p>According to the NCEP ATPIII definition, the most prevalent MS components found in a Danish study<sup>24</sup> were obesity (38.6%), low HDL-c (37.1%) and hypertension (34%), whereas in our study there was a higher prevalence of hypertension (87.2%), hypertriglyceridemia (84.4%) and low HDL-c (58.1%). TC, LDL-c and TG levels were higher in the Danish study<sup>24</sup>, whereas low HDL-c levels were higher in our study. The TC/HDL-c ratio was higher in the Danish study (NCEP ATPIII), and a similar result was found in this study. The incidence of 27.7% of DM found in our study was much higher than the 7% reported in the Danish study<sup>24</sup>.</p>
      <p>Alcohol use and physical activity were more prevalent in this study, unlike smoking, which was more frequent in the Danish study<sup>24</sup> (44% versus 7.4%).</p>
      <p>The most prevalent components of MS in a study conducted in the rural area of the State of Bahia, Brazil<sup>28</sup> were low HDL-c (70.4%) and increased BP (57.1%), whereas in this study they were excess weight and obesity (92.9%), hypertension (87.2%) and hypertriglyceridemia (84.4%). In this study, abdominal obesity, excess weight and low HDL-c were more prevalent in the male gender, unlike in the study in Bahia, where these factors were more prevalent in the female gender.</p>
      <p>
        <bold>Agreement between the two definitions of metabolic syndrome</bold>
      </p>
      <p>The overall agreement as measured by kappa was considered good, thus indicating that both definitions may be used in the clinical practice. Agreement was very good in the female gender, and moderate in the male gender, thus suggesting that the currently used criteria are not very adequate for the male gender (moderate agreement).</p>
      <p>The lower agreement between the two definitions for the diagnosis of MS in the male gender possibly resulted from the parameter used for the characterization of abnormal waist circumference. According to the IDF definition, no difference is found in the prevalence of abnormal waist circumference between genders, whereas according to NCEP ATPIII, 64.6% of women and 43.8% of men have abnormal waist circumference. This suggests that the diagnostic criterion of abnormal WC used by NCEP ATPIII for men may be inadequate and could account for the low agreement observed.</p>
      <p>Our findings are similar to those found by Cristal Lee et al in a study of 22,403 subjects aged <underline>&gt;</underline> 35 years that showed very good agreement between the two definitions among women<sup>29</sup>. Kelliny et al<sup>30</sup> study including 1,218 subjects with mean age of 42 years showed an overall agreement of 0.82 between the definitions<sup>30</sup>.</p>
      <p>
        <bold>Factors associated with metabolic syndrome</bold>
      </p>
      <p>In this study, obesity (BMI <underline>&gt;</underline> 30 kg/m&#178;) after adjusted analysis of risk factors was significantly associated with MS. This result was observed in several other studies such as those conducted in the USA<sup>23</sup> and Chile<sup>25</sup>, as well as in Brazil, in Vit&#243;ria-ES<sup>27</sup>, and Bahia<sup>28</sup>, possibly due to reduced physical activity and increased intake of large amounts of calories in these populations.</p>
      <p>Among Americans<sup>23</sup>, the prevalence of MS was higher among higher-income individuals, unlike in the present study, in which the prevalence was higher among lower-income individuals. Smoking and alcohol use were independently associated with MS in the American study<sup>23</sup>, unlike in ours.</p>
      <p>In this study, the prevalence of MS increased with age, like in the studies conducted in Bahia<sup>28</sup>, Vit&#243;ria<sup>27</sup>, Talca<sup>25</sup>, and United States<sup>23</sup>.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>This study showed that the prevalence of MS in outpatient cardiology clinics was much higher than in the general population. Hypertension was the most prevalent component. Agreement between the two definitions was good for the overall sample, very good for the female gender and moderate for the male gender.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>This study was funded by UDI Hospital.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Jos&#233; Bonif&#225;cio Barbosa, from Universidade Federal do Maranh&#227;o - UFMA.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
